Backstage Authority Control Report: R03 - Authority Change Report
Report Type: SUBJECTS
Created for:
University of Maine
Created on:
April 02 2014

Old version of Record: | New version of Record:
001 D047849 003 DNLM 005 20090831000000.0 008 040707 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aK1.$x400.$x504.$x937.$x500 150 $aCrimean War 450 $wnnna$aCrimean War, 1853-1856 450 $wnnna$aCrimean War, 1853 1856 450 $wnnna$aWar, Crimean 680 $iConflict between RUSSIA (Pre-1917); the OTTOMAN EMPIRE; ENGLAND; FRANCE; and Sardinia. 688 $a2005 | 001 D047849 003 DNLM 005 20130903000000.0 008 040707 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aK1.$x400.$x504.$x937.$x500 150 $aCrimean War 450 $wnnna$aCrimean War, 1853-1856 450 $wnnna$aCrimean War, 1853 1856 450 $wnnna$aWar, Crimean 680 $iConflict between RUSSIA (Pre-1917); the OTTOMAN EMPIRE; ENGLAND; FRANCE; and Sardinia. 688 $a2005
Old version of Record: | New version of Record:
001 D050031 003 DNLM 005 20120905000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC19.$x874.$x871.$x102.$x500 150 $aHashimoto Disease 450 $wnnna$aChronic Lymphocytic Thyroiditis 450 $wnnna$aHashimoto Struma 450 $wnnna$aHashimoto Thyroiditis 450 $wnnna$aHashimoto's Syndrome 450 $aHashimoto's Disease 450 $wnnna$aChronic Lymphocytic Thyroiditides 450 $wnnna$aDisease, Hashimoto 450 $wnnna$aDisease, Hashimoto's 450 $wnnna$aHashimoto Syndrome 450 $wnnna$aHashimoto Thyroiditides 450 $wnnna$aHashimoto's Syndromes 450 $wnnna$aHashimotos Disease 450 $wnnna$aHashimotos Syndrome 450 $wnnna$aLymphocytic Thyroiditides, Chronic 450 $wnnna$aLymphocytic Thyroiditis, Chronic 450 $wnnna$aSyndrome, Hashimoto's 450 $wnnna$aSyndromes, Hashimoto's 450 $wnnna$aThyroiditides, Chronic Lymphocytic 450 $wnnna$aThyroiditides, Hashimoto 450 $wnnna$aThyroiditis, Chronic Lymphocytic 450 $wnnna$aThyroiditis, Hashimoto 680 $iChronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM. 688 $a2006; use THYROIDITIS, AUTOIMMUNE 1975-2005 | 001 D050031 003 DNLM 005 20130903000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC19.$x874.$x871.$x102.$x500 150 $aHashimoto Disease 450 $wnnna$aChronic Lymphocytic Thyroiditis 450 $wnnna$aHashimoto Struma 450 $wnnna$aHashimoto Thyroiditis 450 $wnnna$aHashimoto's Struma 450 $wnnna$aHashimoto's Syndrome 450 $aHashimoto's Disease 450 $wnnna$aChronic Lymphocytic Thyroiditides 450 $wnnna$aDisease, Hashimoto 450 $wnnna$aDisease, Hashimoto's 450 $wnnna$aHashimoto Syndrome 450 $wnnna$aHashimoto Thyroiditides 450 $wnnna$aHashimoto's Syndromes 450 $wnnna$aHashimotos Disease 450 $wnnna$aHashimotos Syndrome 450 $wnnna$aLymphocytic Thyroiditides, Chronic 450 $wnnna$aLymphocytic Thyroiditis, Chronic 450 $wnnna$aSyndrome, Hashimoto's 450 $wnnna$aSyndromes, Hashimoto's 450 $wnnna$aThyroiditides, Chronic Lymphocytic 450 $wnnna$aThyroiditides, Hashimoto 450 $wnnna$aThyroiditis, Chronic Lymphocytic 450 $wnnna$aThyroiditis, Hashimoto 680 $iChronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM. 688 $a2006; use THYROIDITIS, AUTOIMMUNE 1975-2005
Old version of Record: | New version of Record:
001 D050110 003 DNLM 005 20071115000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x65.$x62 072 $aE4.$x62 150 $aBariatric Surgery 450 $wnnna$aBariatric Surgeries 450 $wnnna$aSurgeries, Bariatric 450 $wnnna$aSurgery, Bariatric 550 $aBariatric Medicine 680 $iSurgical procedures aimed at producing major WEIGHT REDUCTION in patients with MORBID OBESITY. 688 $a2006 | 001 D050110 003 DNLM 005 20130903000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x65.$x62 072 $aE4.$x62 150 $aBariatric Surgery 450 $wnnna$aBariatric Surgeries 450 $wnnna$aBariatric Surgical Procedures 450 $wnnna$aMetabolic Surgery 450 $wnnna$aStomach Stapling 450 $wnnna$aBariatric Surgical Procedure 450 $wnnna$aMetabolic Surgeries 450 $wnnna$aProcedure, Bariatric Surgical 450 $wnnna$aProcedures, Bariatric Surgical 450 $wnnna$aStapling, Stomach 450 $wnnna$aSurgeries, Bariatric 450 $wnnna$aSurgeries, Metabolic 450 $wnnna$aSurgery, Bariatric 450 $wnnna$aSurgery, Metabolic 450 $wnnna$aSurgical Procedure, Bariatric 450 $wnnna$aSurgical Procedures, Bariatric 550 $aBariatric Medicine 680 $iSurgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY. 688 $a2006
Old version of Record: | New version of Record:
001 D052244 003 DNLM 005 20110909000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD27.$x505.$x696.$x353 072 $aD27.$x888.$x284.$x295 150 $aEndocrine Disruptors 450 $wnnna$aEndocrine Disruptor Effect 450 $wnnna$aEndocrine Disruptor Effects 450 $aEndocrine Disrupting Chemicals 450 $wnnna$aChemicals, Endocrine Disrupting 450 $wnnna$aDisruptor Effect, Endocrine 450 $wnnna$aDisruptor Effects, Endocrine 450 $wnnna$aDisruptors, Endocrine 450 $wnnna$aEffect, Endocrine Disruptor 450 $wnnna$aEffects, Endocrine Disruptor 550 $aHormones, Hormone Substitutes, and Hormone Antagonists 667 $anote entry term ENDOCRINE DISRUPTOR EFFECT: use only for the endocrine disruptor effect of a chemical substance 680 $iExogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism. 688 $a2006 | 001 D052244 003 DNLM 005 20130903000000.0 008 050630 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD27.$x505.$x696.$x353 072 $aD27.$x888.$x141 150 $aEndocrine Disruptors 450 $wnnna$aEndocrine Disruptor Effect 450 $wnnna$aEndocrine Disruptor Effects 450 $aEndocrine Disrupting Chemicals 450 $wnnna$aChemicals, Endocrine Disrupting 450 $wnnna$aDisruptor Effect, Endocrine 450 $wnnna$aDisruptor Effects, Endocrine 450 $wnnna$aDisruptors, Endocrine 450 $wnnna$aEffect, Endocrine Disruptor 450 $wnnna$aEffects, Endocrine Disruptor 550 $aHormones, Hormone Substitutes, and Hormone Antagonists 667 $anote entry term ENDOCRINE DISRUPTOR EFFECT: use only for the endocrine disruptor effect of a chemical substance 680 $iExogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism. 688 $a2006
Old version of Record: | New version of Record:
001 D053118 003 DNLM 005 20090831000000.0 008 051110 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB4.$x820.$x545.$x405.$x400.$x214 072 $aB4.$x909.$x777.$x545.$x405.$x400.$x214 150 $aInfluenza A Virus, H1N1 Subtype 450 $aH1N1 Virus 450 $aSwine-Origin Influenza A H1N1 Virus 450 $wnnna$aH1N1 Viruses 450 $wnnna$aSwine Origin Influenza A H1N1 Virus 450 $wnnna$aVirus, H1N1 450 $wnnna$aViruses, H1N1 667 $ainfection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals 680 $iA subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918. 688 $a2006 | 001 D053118 003 DNLM 005 20130903000000.0 008 051110 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB4.$x820.$x545.$x405.$x400.$x214 072 $aB4.$x909.$x777.$x545.$x405.$x400.$x214 150 $aInfluenza A Virus, H1N1 Subtype 450 $aH1N1 Virus 450 $aSwine-Origin Influenza A H1N1 Virus 450 $wnnna$aH1N1 Viruses 450 $wnnna$aSwine Origin Influenza A H1N1 Virus 450 $wnnna$aVirus, H1N1 450 $wnnna$aViruses, H1N1 550 $aInfluenza Pandemic, 1918-1919 667 $ainfection: coordinate IM with INFLUENZA, HUMAN (IM) in humans, or INFLUENZA IN BIRDS (IM) in birds, or ORTHOMYXOVIRIDAE INFECTIONS (IM) in other animals 680 $iA subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918. 688 $a2006
Old version of Record: | New version of Record:
001 D002446 003 DNLM 005 20120905000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x469.$x637.$x250 072 $aC18.$x452.$x603.$x250 150 $aCeliac Disease 450 $wnnna$aCeliac Sprue 450 $wnnna$aGluten-Sensitive Enteropathy 450 $aGluten Enteropathy 450 $aSprue, Celiac 450 $aSprue, Nontropical 450 $wnnna$aDisease, Celiac 450 $wnnna$aEnteropathies, Gluten 450 $wnnna$aEnteropathies, Gluten-Sensitive 450 $wnnna$aEnteropathy, Gluten 450 $wnnna$aEnteropathy, Gluten-Sensitive 450 $wnnna$aGluten Enteropathies 450 $wnnna$aGluten Sensitive Enteropathy 450 $wnnna$aGluten-Sensitive Enteropathies 450 $wnnna$aNontropical Sprue 550 $aSprue, Tropical 550 $aWheat Hypersensitivity 550 $aEnteropathy-Associated T-Cell Lymphoma 667 $ado not confuse with SPRUE, TROPICAL 680 $iA malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION. | 001 D002446 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x469.$x637.$x250 072 $aC18.$x452.$x603.$x250 150 $aCeliac Disease 450 $wnnna$aCeliac Sprue 450 $wnnna$aGluten-Sensitive Enteropathy 450 $wnnna$aSprue 450 $aGluten Enteropathy 450 $aSprue, Celiac 450 $aSprue, Nontropical 450 $wnnna$aDisease, Celiac 450 $wnnna$aEnteropathies, Gluten 450 $wnnna$aEnteropathies, Gluten-Sensitive 450 $wnnna$aEnteropathy, Gluten 450 $wnnna$aEnteropathy, Gluten-Sensitive 450 $wnnna$aGluten Enteropathies 450 $wnnna$aGluten Sensitive Enteropathy 450 $wnnna$aGluten-Sensitive Enteropathies 450 $wnnna$aNontropical Sprue 550 $aSprue, Tropical 550 $aWheat Hypersensitivity 550 $aEnteropathy-Associated T-Cell Lymphoma 667 $ado not confuse with SPRUE, TROPICAL 680 $iA malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
Old version of Record: | New version of Record:
001 D053595 003 DNLM 005 20071115000000.0 008 060705 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x872.$x190 150 $aEmbryonic Stem Cells 450 $aStem Cells, Embryonic 450 $wnnna$aCell, Embryonic Stem 450 $wnnna$aCells, Embryonic Stem 450 $wnnna$aEmbryonic Stem Cell 450 $wnnna$aStem Cell, Embryonic 550 $aBlastocyst Inner Cell Mass 680 $iCells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells. 688 $a2007 | 001 D053595 003 DNLM 005 20130903000000.0 008 060705 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x872.$x190 150 $aEmbryonic Stem Cells 450 $aStem Cells, Embryonic 450 $wnnna$aCell, Embryonic Stem 450 $wnnna$aCells, Embryonic Stem 450 $wnnna$aEmbryonic Stem Cell 450 $wnnna$aStem Cell, Embryonic 550 $aBlastocyst Inner Cell Mass 680 $iCells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells. 688 $a2007
Old version of Record: | New version of Record:
001 D002478 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x251 150 $aCells, Cultured 450 $aCultured Cells 450 $wnnna$aCell, Cultured 450 $wnnna$aCultured Cell 550 $aOrgan Culture Techniques 550 $aCoculture Techniques 550 $aCell Culture Techniques 550 $aCulture Techniques 550 $aHuman Umbilical Vein Endothelial Cells 667 $a note category: do not confuse with CELL CULTURE TECHNIQUES (Cat E); not for bact or other micro-organisms; almost always NIM with no subheadings; check HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available 680 $iCells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. 688 $a72 | 001 D002478 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x251 150 $aCells, Cultured 450 $aCultured Cells 450 $wnnna$aCell, Cultured 450 $wnnna$aCultured Cell 550 $aOrgan Culture Techniques 550 $aCoculture Techniques 550 $aCell Culture Techniques 550 $aCulture Techniques 550 $aHuman Umbilical Vein Endothelial Cells 667 $a note category: do not confuse with CELL CULTURE TECHNIQUES (Cat E); not for bact or other micro-organisms; almost always NIM with no subheadings; check HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available 680 $iCells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. 688 $a72
Old version of Record: | New version of Record:
001 D053687 003 DNLM 005 20071115000000.0 008 060705 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x872.$x40 150 $aAdult Stem Cells 450 $wnnna$aAdult Stem Cell 450 $wnnna$aCell, Adult Stem 450 $wnnna$aCells, Adult Stem 450 $wnnna$aStem Cell, Adult 450 $wnnna$aStem Cells, Adult 680 $iCells with high proliferative and self renewal capacities derived from adults. 688 $a2007 | 001 D053687 003 DNLM 005 20130903000000.0 008 060705 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x872.$x40 150 $aAdult Stem Cells 450 $wnnna$aAdult Germline Stem Cells 450 $wnnna$aAdult Somatic Stem Cells 450 $wnnna$aGermline Adult Stem Cells 450 $wnnna$aOogonial Stem Cells 450 $wnnna$aSomatic Adult Stem Cells 450 $wnnna$aSpermatogonial Progenitor Cells 450 $wnnna$aAdult Stem Cell 450 $wnnna$aCell, Adult Stem 450 $wnnna$aCell, Oogonial Stem 450 $wnnna$aCell, Spermatogonial Progenitor 450 $wnnna$aCells, Adult Stem 450 $wnnna$aCells, Oogonial Stem 450 $wnnna$aCells, Spermatogonial Progenitor 450 $wnnna$aOogonial Stem Cell 450 $wnnna$aProgenitor Cell, Spermatogonial 450 $wnnna$aProgenitor Cells, Spermatogonial 450 $wnnna$aSpermatogonial Progenitor Cell 450 $wnnna$aStem Cell, Adult 450 $wnnna$aStem Cell, Oogonial 450 $wnnna$aStem Cells, Adult 450 $wnnna$aStem Cells, Oogonial 680 $iCells with high proliferative and self renewal capacities derived from adults. 688 $a2007
Old version of Record: | New version of Record:
001 D002487 003 DNLM 005 20071115000000.0 008 770512 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aI1.$x409.$x137.$x500.$x600.$x650.$x225 072 $aN3.$x540.$x348.$x500.$x500.$x600.$x650.$x225 150 $aCenters for Disease Control and Prevention (U.S.) 450 $wnnna$aCDC 450 $wnnna$aCDCP 450 $wnnna$aCenter for Disease Control 450 $wnnna$aCenter for Disease Control and Prevention 450 $wnnna$aCenters for Disease Control 450 $wnnna$aCenters for Disease Control and Prevention 450 $wnnna$aUnited States Centers for Disease Control 450 $aCenters for Disease Control (U.S.) 450 $aUnited States Centers for Disease Control and Prevention 667 $aadd UNITED STATES (NIM); research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; DF: CDC or CDCP CATALOG: use NAF entry 680 $iAn agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries. 688 $a94; was CENTERS FOR DISEASE CONTROL (U.S.) 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93 | 001 D002487 003 DNLM 005 20130903000000.0 008 770512 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aI1.$x409.$x137.$x500.$x600.$x650.$x225 072 $aN3.$x540.$x348.$x500.$x500.$x600.$x650.$x225 150 $aCenters for Disease Control and Prevention (U.S.) 450 $wnnna$aCDC 450 $wnnna$aCDCP 450 $wnnna$aCenter for Disease Control 450 $wnnna$aCenter for Disease Control and Prevention 450 $wnnna$aCenters for Disease Control 450 $wnnna$aCenters for Disease Control and Prevention 450 $wnnna$aUnited States Centers for Disease Control 450 $aCenters for Disease Control (U.S.) 450 $aUnited States Centers for Disease Control and Prevention 667 $aadd UNITED STATES (NIM); research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; DF: CDC or CDCP CATALOG: use NAF entry 680 $iAn agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries. 688 $a94; was CENTERS FOR DISEASE CONTROL (U.S.) 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93
Old version of Record: | New version of Record:
001 D053685 003 DNLM 005 20081103000000.0 008 070709 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x594 072 $aE4.$x14.$x520 150 $aLaser Therapy 450 $wnnna$aLaser Ablation 450 $wnnna$aLaser Knives 450 $wnnna$aLaser Photoablation of Tissue 450 $wnnna$aLaser Surgery 450 $wnnna$aLaser Tissue Ablation 450 $wnnna$aNonablative Laser Treatment 450 $wnnna$aPulsed Laser Tissue Ablation 450 $aLaser Knife 450 $aLaser Scalpel 450 $aSurgery, Laser 450 $aVaporization, Laser 450 $wnnna$aAblation, Laser 450 $wnnna$aAblation, Laser Tissue 450 $wnnna$aKnife, Laser 450 $wnnna$aKnifes, Laser 450 $wnnna$aKnive, Laser 450 $wnnna$aKnives, Laser 450 $wnnna$aLaser Knifes 450 $wnnna$aLaser Knive 450 $wnnna$aLaser Scalpels 450 $wnnna$aLaser Surgeries 450 $wnnna$aLaser Therapies 450 $wnnna$aLaser Treatment, Nonablative 450 $wnnna$aLaser Treatments, Nonablative 450 $wnnna$aLaser Vaporization 450 $wnnna$aNonablative Laser Treatments 450 $wnnna$aScalpel, Laser 450 $wnnna$aScalpels, Laser 450 $wnnna$aSurgeries, Laser 450 $wnnna$aTherapies, Laser 450 $wnnna$aTherapy, Laser 450 $wnnna$aTissue Ablation, Laser 450 $aLasers$xtherapeutic use 667 $ageneral; prefer specifics or specific laser term/ ther use; coordinate with disease and/or organ /surg; LASER THERAPY, LOW-LEVEL is also available; laser surgery of cataract = LASER SURGERY (IM) see LASER THERAPY + CATARACT EXTRACTION (IM) 680 $iThe use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue. 688 $a2008 | 001 D053685 003 DNLM 005 20130903000000.0 008 070709 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x594 072 $aE4.$x14.$x520 150 $aLaser Therapy 450 $wnnna$aLaser Ablation 450 $wnnna$aLaser Knives 450 $wnnna$aLaser Photoablation of Tissue 450 $wnnna$aLaser Surgery 450 $wnnna$aLaser Tissue Ablation 450 $wnnna$aNonablative Laser Treatment 450 $wnnna$aPulsed Laser Tissue Ablation 450 $aLaser Knife 450 $aLaser Scalpel 450 $aSurgery, Laser 450 $aVaporization, Laser 450 $wnnna$aAblation, Laser 450 $wnnna$aAblation, Laser Tissue 450 $wnnna$aKnife, Laser 450 $wnnna$aKnifes, Laser 450 $wnnna$aKnive, Laser 450 $wnnna$aKnives, Laser 450 $wnnna$aLaser Knifes 450 $wnnna$aLaser Knive 450 $wnnna$aLaser Scalpels 450 $wnnna$aLaser Surgeries 450 $wnnna$aLaser Therapies 450 $wnnna$aLaser Treatment, Nonablative 450 $wnnna$aLaser Treatments, Nonablative 450 $wnnna$aLaser Vaporization 450 $wnnna$aNonablative Laser Treatments 450 $wnnna$aScalpel, Laser 450 $wnnna$aScalpels, Laser 450 $wnnna$aSurgeries, Laser 450 $wnnna$aTherapies, Laser 450 $wnnna$aTherapy, Laser 450 $wnnna$aTissue Ablation, Laser 450 $aLasers$xtherapeutic use 667 $ageneral; prefer specifics or specific laser term/ ther use; coordinate with disease and/or organ /surg; LASER THERAPY, LOW-LEVEL is also available; laser surgery of cataract = LASER SURGERY (IM) see LASER THERAPY + CATARACT EXTRACTION (IM) 680 $iThe use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue. 688 $a2008
Old version of Record: | New version of Record:
001 D002503 003 DNLM 005 20081103000000.0 008 770429 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x165 072 $aG5.$x360.$x160.$x165 150 $aCentromere 450 $wnnna$aCentromeres 550 $aDNA, Satellite 550 $aMitotic Spindle Apparatus 550 $aCentromere Protein B 680 $iThe clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. 688 $a91(78); was see under CHROMOSOMES 1978-90 | 001 D002503 003 DNLM 005 20130903000000.0 008 770429 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x165 072 $aG5.$x360.$x160.$x165 150 $aCentromere 450 $wnnna$aCentromeres 550 $aDNA, Satellite 550 $aSpindle Apparatus 550 $aCentromere Protein B 680 $iThe clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. 688 $a91(78); was see under CHROMOSOMES 1978-90
Old version of Record: | New version of Record:
001 D054542 003 DNLM 005 20120905000000.0 008 070709 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aK1.$x400.$x504.$x984.$x249 150 $aIraq War, 2003 - 2011 450 $wnnna$aGulf War II, 2003- 450 $wnnna$aGulf War, 2003 450 $wnnna$aGulf War, 2003 - 2011 450 $wnnna$aOperation Iraqi Freedom, 2003 - 2011 450 $wnnna$aOperation Iraqi Freedom, 2003- 450 $wnnna$aPersian Gulf War 450 $aIraq War, 2003 - 450 $wnnna$a2003 Gulf War 450 $wnnna$aGulf War II, 2003 450 $wnnna$aGulf War, 2003 2011 450 $wnnna$aGulf Wars, 2003 450 $wnnna$aIraq War, 2003 450 $wnnna$aOperation Iraqi Freedom, 2003 450 $wnnna$aOperation Iraqi Freedom, 2003 2011 680 $iAn armed intervention involving multi-national forces in the country of IRAQ. 688 $a2008 | 001 D054542 003 DNLM 005 20130903000000.0 008 070709 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aK1.$x400.$x504.$x984.$x249 150 $aIraq War, 2003-2011 450 $wnnna$a2003-2011 Iraq Wars 450 $wnnna$aIraq War, 2003 2011 450 $wnnna$aIraq Wars, 2003-2011 680 $iAn armed intervention involving multi-national forces in the country of IRAQ. 688 $a2008
Old version of Record: | New version of Record:
001 D055048 003 DNLM 005 20081103000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x400 150 $aIntegrative Medicine 450 $wnnna$aMedicine, Integrative 680 $iThe discipline concerned with using the combination of conventional (allopathic) medicine and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness. 688 $a2009 | 001 D055048 003 DNLM 005 20130903000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x400 150 $aIntegrative Medicine 450 $wnnna$aMedicine, Integrative 680 $iThe discipline concerned with using the combination of conventional ALLOPATHIC MEDICINE and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness. 688 $a2009
Old version of Record: | New version of Record:
001 D055553 003 DNLM 005 20090831000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x670 150 $aPrescription Drugs 550 $aBehind-the-Counter Drugs 667 $anote category: do not confuse with DRUG PRESCRIPTIONS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed 680 $iDrugs that cannot be sold legally without a prescription. 688 $a2009 | 001 D055553 003 DNLM 005 20130903000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x670 150 $aPrescription Drugs 550 $aBehind-the-Counter Drugs 667 $anote category: do not confuse with DRUG PRESCRIPTIONS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed 680 $iDrugs that cannot be sold legally without a prescription. 688 $a2009
Old version of Record: | New version of Record:
001 D055812 003 DNLM 005 20100901000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x770.$x644.$x193 072 $aN5.$x425.$x104 150 $aCommunity-Based Participatory Research 450 $wnnna$aCommunity Based Participatory Research 450 $wnnna$aParticipatory Research, Community-Based 680 $iCollaborative process of research involving researchers and community representatives. 688 $a2009 | 001 D055812 003 DNLM 005 20130903000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x770.$x644.$x193 072 $aN5.$x425.$x104 150 $aCommunity-Based Participatory Research 450 $wnnna$aConsumer-Driven Community-Based Research 450 $wnnna$aCommunity Based Participatory Research 450 $wnnna$aCommunity-Based Research, Consumer-Driven 450 $wnnna$aCommunity-Based Researchs, Consumer-Driven 450 $wnnna$aConsumer Driven Community Based Research 450 $wnnna$aConsumer-Driven Community-Based Researchs 450 $wnnna$aParticipatory Research, Community-Based 450 $wnnna$aResearch, Consumer-Driven Community-Based 450 $wnnna$aResearchs, Consumer-Driven Community-Based 680 $iCollaborative process of research involving researchers and community representatives. 688 $a2009
Old version of Record: | New version of Record:
001 D055866 003 DNLM 005 20081103000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG1.$x311.$x340.$x224 072 $aG1.$x595.$x340.$x224 150 $aEarthquakes 450 $wnnna$aEarthquake 667 $acoordinate with DISASTERS if pertinent; specify geographic location 680 $iSudden slips on a fault, and the resulting ground shaking and radiated seismic energy caused by the slips, or by volcanic or magmatic activity, or other sudden stress changes in the earth. Faults are fractures along which the blocks of EARTH crust on either side have moved relative to one another parallel to the fracture. 688 $a2009; use DISASTERS 1976-2008 | 001 D055866 003 DNLM 005 20130903000000.0 008 080708 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG1.$x311.$x340.$x224 072 $aG1.$x595.$x340.$x224 150 $aEarthquakes 450 $wnnna$aEarthquake 667 $acoordinate with DISASTERS if pertinent; specify geographic location 680 $iSudden slips on a fault, and the resulting ground shaking and radiated seismic energy caused by the slips, or by volcanic or magmatic activity, or other sudden stress changes in the earth. Faults are fractures along which the blocks of EARTH crust on either side have moved relative to one another parallel to the fracture. 688 $a2009; use DISASTERS 1976-2008
Old version of Record: | New version of Record:
001 D057186 003 DNLM 005 20100901000000.0 008 090706 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x770.$x644.$x145.$x360.$x500 072 $aN5.$x425.$x157 150 $aComparative Effectiveness Research 450 $wnnna$aEffectiveness Research, Comparative 450 $wnnna$aResearch, Comparative Effectiveness 680 $iConduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009) 688 $a2010 | 001 D057186 003 DNLM 005 20130903000000.0 008 090706 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x770.$x644.$x145.$x360.$x500 072 $aN5.$x425.$x157 150 $aComparative Effectiveness Research 450 $wnnna$aEffectiveness Research, Comparative 450 $wnnna$aResearch, Comparative Effectiveness 550 $aPragmatic Clinical Trials as Topic 680 $iConduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009) 688 $a2010
Old version of Record: | New version of Record:
001 D057192 003 DNLM 005 20090831000000.0 008 090706 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG1.$x311.$x340.$x843 072 $aG1.$x595.$x340.$x787 150 $aTsunamis 450 $aTsunami 667 $acoordinate with DISASTERS if pertinent; specify geographic location 680 $iSeries of ocean waves produced by geologic events or underwater LANDSLIDES. These waves can travel at speeds averaging 450 (and up to 600) miles per hour in the open ocean. 688 $a2010; use TIDAL WAVES (2009) | 001 D057192 003 DNLM 005 20130903000000.0 008 090706 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG1.$x311.$x340.$x843 072 $aG1.$x595.$x340.$x787 150 $aTsunamis 450 $aTsunami 667 $acoordinate with DISASTERS if pertinent; specify geographic location 680 $iSeries of ocean waves produced by geologic events or underwater LANDSLIDES. These waves can travel at speeds averaging 450 (and up to 600) miles per hour in the open ocean. 688 $a2010; use TIDAL WAVES (2009)
Old version of Record: | New version of Record:
001 D002607 003 DNLM 005 20120905000000.0 008 991108 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x500.$x300.$x200 072 $aC10.$x574.$x500.$x495.$x200 072 $aC10.$x668.$x829.$x800.$x300.$x200 072 $aC16.$x131.$x666.$x300.$x200 072 $aC16.$x320.$x400.$x375.$x200 150 $aCharcot-Marie-Tooth Disease 450 $wnnna$aCharcot-Marie Disease 450 $wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1a 450 $wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1b 450 $wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy 450 $wnnna$aCharcot-Marie-Tooth Disease, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Disease, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Disease, Type I 450 $wnnna$aCharcot-Marie-Tooth Disease, Type Ia 450 $wnnna$aCharcot-Marie-Tooth Disease, Type Ib 450 $wnnna$aCharcot-Marie-Tooth Disease, Type II 450 $wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1a 450 $wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1b 450 $wnnna$aHMSN Ia 450 $wnnna$aHMSN Ib 450 $wnnna$aHMN Distal Type I 450 $wnnna$aHMSN 1A 450 $wnnna$aHMSN 1B 450 $wnnna$aHMSN I 450 $wnnna$aHMSN1a 450 $wnnna$aHMSN1b 450 $wnnna$aHMSN II 450 $wnnna$aHereditary Motor And Sensory Neuropathy I 450 $wnnna$aHereditary Motor And Sensory Neuropathy Ia 450 $wnnna$aHereditary Areflexic Dystasia 450 $wnnna$aHereditary Motor And Sensory Neuropathy Ib 450 $wnnna$aHereditary Motor and Sensory Neuropathy 1A 450 $wnnna$aHereditary Motor and Sensory Neuropathy 1B 450 $wnnna$aCharcot Marie Tooth Disease, Type Ia 450 $wnnna$aHereditary Type I Motor and Sensory Neuropathy 450 $wnnna$aNeuropathy, Type I Hereditary Motor and Sensory 450 $wnnna$aNeuropathy, Type II Hereditary Motor and Sensory 450 $wnnna$aRoussy Levy Hereditary Areflexic Dystasia 450 $wnnna$aRoussy-Levy Disease 450 $wnnna$aRoussy-Levy Hereditary Areflexic Dystasia 450 $aAtrophy, Muscular, Peroneal 450 $aHMSN Type I 450 $aHMSN Type II 450 $aHereditary Motor and Sensory-Neuropathy Type II 450 $aHereditary Motor, and Sensory Neuropathy Type I 450 $aMuscular Atrophy, Peroneal 450 $aPeroneal Muscular Atrophy 450 $aRoussy-Levy Syndrome 450 $wnnna$aAreflexic Dystasia, Hereditary 450 $wnnna$aAreflexic Dystasias, Hereditary 450 $wnnna$aAtrophies, Peroneal Muscular 450 $wnnna$aAtrophy, Peroneal Muscular 450 $wnnna$aCharcot Marie Disease 450 $wnnna$aCharcot Marie Tooth Disease 450 $wnnna$aCharcot Marie Tooth Disease, Type 1A 450 $wnnna$aCharcot Marie Tooth Disease, Type 1B 450 $wnnna$aCharcot Marie Tooth Disease, Type I 450 $wnnna$aCharcot Marie Tooth Disease, Type Ib 450 $wnnna$aCharcot Marie Tooth Neuropathy, Type 1a 450 $wnnna$aCharcot Marie Tooth Disease, Type II 450 $wnnna$aCharcot Marie Tooth Neuropathy, Type 1b 450 $wnnna$aHMSN 1As 450 $wnnna$aHMSN 1Bs 450 $wnnna$aHMSN IIs 450 $wnnna$aDystasia, Hereditary Areflexic 450 $wnnna$aDystasias, Hereditary Areflexic 450 $wnnna$aHereditary Areflexic Dystasias 450 $wnnna$aHereditary Motor and Sensory Neuropathy Type II 450 $wnnna$aHMSN Is 450 $wnnna$aMuscular Atrophies, Peroneal 450 $wnnna$aPeroneal Muscular Atrophies 450 $wnnna$aRoussy Levy Disease 450 $wnnna$aRoussy Levy Syndrome 450 $wnnna$aHMSN Type IIs 450 $wnnna$aSyndrome, Roussy-Levy 450 $wnnna$aHMSN Type Is 550 $aMyelin P0 Protein 550 $aEarly Growth Response Protein 2 680 $iA hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343) 688 $a2000(1966) | 001 D002607 003 DNLM 005 20130903000000.0 008 991108 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x500.$x300.$x200 072 $aC10.$x574.$x500.$x495.$x200 072 $aC10.$x668.$x829.$x800.$x300.$x200 072 $aC16.$x131.$x666.$x300.$x200 072 $aC16.$x320.$x400.$x375.$x200 150 $aCharcot-Marie-Tooth Disease 450 $wnnna$aCharcot-Marie Disease 450 $wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy 450 $wnnna$aCharcot-Marie-Tooth Disease, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Disease, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Disease, Type I 450 $wnnna$aCharcot-Marie-Tooth Disease, Type IA 450 $wnnna$aCharcot-Marie-Tooth Disease, Type IB 450 $wnnna$aCharcot-Marie-Tooth Disease, Type II 450 $wnnna$aCharcot-Marie-Tooth Hereditary Neuropathy 450 $wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1A 450 $wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1B 450 $wnnna$aCharcot-Marie-Tooth Syndrome 450 $wnnna$aHMN Distal Type I 450 $wnnna$aHMSN 1A 450 $wnnna$aHMSN 1B 450 $wnnna$aHMSN I 450 $wnnna$aHMSN IA 450 $wnnna$aHMSN IB 450 $wnnna$aHMSN II 450 $wnnna$aHMSN1A 450 $wnnna$aHMSN1B 450 $wnnna$aHereditary Areflexic Dystasia 450 $wnnna$aHereditary Motor And Sensory Neuropathy IB 450 $wnnna$aHereditary Motor and Sensory Neuropathy 1A 450 $wnnna$aHereditary Motor and Sensory Neuropathy 1B 450 $wnnna$aHereditary Motor and Sensory Neuropathy IA 450 $wnnna$aHereditary Type I Motor and Sensory Neuropathy 450 $wnnna$aNeuropathy, Type I Hereditary Motor and Sensory 450 $wnnna$aNeuropathy, Type II Hereditary Motor and Sensory 450 $wnnna$aRoussy Levy Hereditary Areflexic Dystasia 450 $wnnna$aRoussy-Levy Disease 450 $wnnna$aRoussy-Levy Hereditary Areflexic Dystasia 450 $aAtrophy, Muscular, Peroneal 450 $aHMSN Type I 450 $aHMSN Type II 450 $aHereditary Motor and Sensory-Neuropathy Type II 450 $aHereditary Motor, and Sensory Neuropathy Type I 450 $aMuscular Atrophy, Peroneal 450 $aPeroneal Muscular Atrophy 450 $aRoussy-Levy Syndrome 450 $wnnna$aAreflexic Dystasia, Hereditary 450 $wnnna$aAreflexic Dystasias, Hereditary 450 $wnnna$aAtrophies, Peroneal Muscular 450 $wnnna$aAtrophy, Peroneal Muscular 450 $wnnna$aCharcot Marie Disease 450 $wnnna$aCharcot Marie Tooth Disease 450 $wnnna$aCharcot Marie Tooth Disease, Type 1A 450 $wnnna$aCharcot Marie Tooth Disease, Type 1B 450 $wnnna$aCharcot Marie Tooth Disease, Type I 450 $wnnna$aCharcot Marie Tooth Disease, Type IA 450 $wnnna$aCharcot Marie Tooth Disease, Type IB 450 $wnnna$aCharcot Marie Tooth Disease, Type II 450 $wnnna$aCharcot Marie Tooth Hereditary Neuropathy 450 $wnnna$aCharcot Marie Tooth Neuropathy, Type 1A 450 $wnnna$aCharcot Marie Tooth Neuropathy, Type 1B 450 $wnnna$aCharcot Marie Tooth Syndrome 450 $wnnna$aDystasia, Hereditary Areflexic 450 $wnnna$aDystasias, Hereditary Areflexic 450 $wnnna$aHereditary Areflexic Dystasias 450 $wnnna$aHereditary Motor and Sensory Neuropathy Type II 450 $wnnna$aHereditary Neuropathy, Charcot-Marie-Tooth 450 $wnnna$aMuscular Atrophies, Peroneal 450 $wnnna$aPeroneal Muscular Atrophies 450 $wnnna$aRoussy Levy Disease 450 $wnnna$aRoussy Levy Syndrome 450 $wnnna$aSyndrome, Charcot-Marie-Tooth 450 $wnnna$aSyndrome, Roussy-Levy 550 $aMyelin P0 Protein 550 $aEarly Growth Response Protein 2 680 $iA hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343) 688 $a2000(1966)
Old version of Record: | New version of Record:
001 D002621 003 DNLM 005 20090831000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x181 150 $aChemistry 667 $athe discipline (education, history, etc) only; use CHEMICAL PHENOMENA or specifics treed under it for characteristics of chemicals and their reactions; the qualifier / chemistry is available for use with specific anatomical terms, lower organisms and chemicals; DF: CHEM 680 $iA basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange. | 001 D002621 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x181 150 $aChemistry 667 $athe discipline (education, history, etc) only; use CHEMICAL PHENOMENA or specifics treed under it for characteristics of chemicals and their reactions; the qualifier / chemistry is available for use with specific anatomical terms, lower organisms and chemicals; DF: CHEM 680 $iA basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
Old version of Record: | New version of Record:
001 D058110 003 DNLM 005 20100901000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x99 150 $aCounterfeit Drugs 450 $wnnna$aCounterfeit Medicines 450 $wnnna$aDrug Counterfeiting 450 $wnnna$aFake Drugs 450 $wnnna$aCounterfeiting, Drug 450 $wnnna$aDrugs, Counterfeit 450 $wnnna$aDrugs, Fake 450 $wnnna$aMedicines, Counterfeit 667 $aentry term DRUG COUNTERFEITING: coordinate with FRAUD 680 $iDrugs manufactured and sold with the intent to misrepresent its origin, authenticity, chemical composition, and or efficacy. Counterfeit drugs may contain inappropriate quantities of ingredients not listed on the label or package. In order to further deceive the consumer, the packaging, container, or labeling, may be inaccurate, incorrect, or fake. 688 $a2011 | 001 D058110 003 DNLM 005 20130903000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x99 150 $aCounterfeit Drugs 450 $wnnna$aCounterfeit Medicines 450 $wnnna$aDrug Counterfeiting 450 $wnnna$aFake Drugs 450 $wnnna$aCounterfeiting, Drug 450 $wnnna$aDrugs, Counterfeit 450 $wnnna$aDrugs, Fake 450 $wnnna$aMedicines, Counterfeit 667 $aentry term DRUG COUNTERFEITING: coordinate with FRAUD 680 $iDrugs manufactured and sold with the intent to misrepresent its origin, authenticity, chemical composition, and or efficacy. Counterfeit drugs may contain inappropriate quantities of ingredients not listed on the label or package. In order to further deceive the consumer, the packaging, container, or labeling, may be inaccurate, incorrect, or fake. 688 $a2011
Old version of Record: | New version of Record:
001 D059019 003 DNLM 005 20100901000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN4.$x452.$x758.$x708.$x200.$x400.$x500 072 $aN4.$x452.$x859.$x564.$x274 072 $aN5.$x715.$x360.$x300.$x715.$x500.$x249 072 $aN6.$x850.$x520.$x308.$x940.$x968.$x249 150 $aClinical Coding 450 $wnnna$aCoding 450 $wnnna$aMedical Coding 450 $wnnna$aCoding, Clinical 450 $wnnna$aCoding, Medical 680 $iProcess of substituting a symbol or code for a term such as a diagnosis or procedure. (from Slee's Health Care Terms, 3d ed.) 688 $a2011; for CODING use FORMS AND RECORDS CONTROL 1978-2010 | 001 D059019 003 DNLM 005 20130903000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN4.$x452.$x758.$x708.$x200.$x400.$x500 072 $aN4.$x452.$x859.$x564.$x274 072 $aN5.$x715.$x360.$x300.$x715.$x500.$x249 072 $aN6.$x850.$x520.$x308.$x940.$x968.$x249 150 $aClinical Coding 450 $wnnna$aCoding 450 $wnnna$aMedical Coding 450 $wnnna$aCoding, Clinical 450 $wnnna$aCoding, Medical 680 $iProcess of substituting a symbol or code for a term such as a diagnosis or procedure. (from Slee's Health Care Terms, 3d ed.) 688 $a2011; for CODING use FORMS AND RECORDS CONTROL 1978-2010
Old version of Record: | New version of Record:
001 D059022 003 DNLM 005 20120905000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aJ1.$x576.$x423.$x850.$x730.$x500 072 $aN6.$x850.$x601.$x500 150 $aFood Safety 450 $wnnna$aSafety, Food 680 $iActivities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination. 688 $a2011 | 001 D059022 003 DNLM 005 20130903000000.0 008 100625 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aJ1.$x576.$x423.$x850.$x730.$x500 072 $aN6.$x850.$x601.$x500 150 $aFood Safety 450 $wnnna$aSafety, Food 550 $aHazard Analysis and Critical Control Points 680 $iActivities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination. 688 $a2011
Old version of Record: | New version of Record:
001 D059408 003 DNLM 005 20110909000000.0 008 110701 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x745 072 $aN4.$x590.$x607.$x500 150 $aPain Management 450 $wnnna$aManagement, Pain 450 $wnnna$aManagements, Pain 450 $wnnna$aPain Managements 450 $aPain$xtherapy 550 $aChronic Disease 680 $iA form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain. 688 $a2012 | 001 D059408 003 DNLM 005 20130903000000.0 008 110701 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE2.$x745 072 $aN4.$x590.$x607.$x500 150 $aPain Management 450 $wnnna$aManagement, Pain 450 $wnnna$aManagements, Pain 450 $wnnna$aPain Managements 450 $aPain$xtherapy 550 $aChronic Disease 667 $aconsider also PALLIATIVE CARE 680 $iA form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain. 688 $a2012
Old version of Record: | New version of Record:
001 D002794 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x33.$x100.$x291.$x211 072 $aD2.$x92.$x63.$x291.$x211 072 $aD2.$x92.$x877.$x883.$x333 072 $aD2.$x675.$x276.$x232 150 $aCholine 450 $wnnna$a2-Hydroxy-N,N,N-trimethylethanaminium 450 $wnnna$aCholine Bitartrate 450 $wnnna$aCholine Chloride 450 $wnnna$aCholine Citrate 450 $wnnna$aCholine O-Sulfate 450 $aBursine 450 $aFagine 450 $aVidine 450 $wnnna$aBitartrate, Choline 450 $wnnna$aChloride, Choline 450 $wnnna$aCholine O Sulfate 450 $wnnna$aCitrate, Choline 450 $wnnna$aO-Sulfate, Choline 667 $a/biosyn /physiol permitted 680 $iA basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. | 001 D002794 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x33.$x100.$x291.$x211 072 $aD2.$x92.$x63.$x291.$x211 072 $aD2.$x92.$x877.$x883.$x333 072 $aD2.$x675.$x276.$x232 150 $aCholine 450 $wnnna$a2-Hydroxy-N,N,N-trimethylethanaminium 450 $wnnna$aCholine Bitartrate 450 $wnnna$aCholine Chloride 450 $wnnna$aCholine Citrate 450 $wnnna$aCholine Hydroxide 450 $wnnna$aCholine O-Sulfate 450 $aBursine 450 $aFagine 450 $aVidine 450 $wnnna$aBitartrate, Choline 450 $wnnna$aChloride, Choline 450 $wnnna$aCholine O Sulfate 450 $wnnna$aCitrate, Choline 450 $wnnna$aHydroxide, Choline 450 $wnnna$aO-Sulfate, Choline 667 $a/biosyn /physiol permitted 680 $iA basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.
Old version of Record: | New version of Record:
001 D002816 003 DNLM 005 20090831000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x50.$x150.$x200 072 $aB1.$x50.$x500.$x272 150 $aChordata, Nonvertebrate 450 $wnnna$aChordatas, Nonvertebrate 450 $wnnna$aNonvertebrate Chordata 450 $wnnna$aNonvertebrate Chordatas 680 $iA portion of the animal phylum Chordata comprised of the subphyla Cephalochordata, UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata (VERTEBRATES). It includes nonvertebrate animals having a NOTOCHORD during some developmental stage. 688 $a2000(1966) | 001 D002816 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x50.$x150.$x200 072 $aB1.$x50.$x500.$x272 150 $aChordata, Nonvertebrate 450 $wnnna$aInvertebrate Chordate 450 $wnnna$aChordatas, Nonvertebrate 450 $wnnna$aChordate, Invertebrate 450 $wnnna$aChordates, Invertebrate 450 $wnnna$aInvertebrate Chordates 450 $wnnna$aNonvertebrate Chordata 450 $wnnna$aNonvertebrate Chordatas 680 $iA portion of the animal phylum Chordata comprised of the subphyla CEPHALOCHORDATA; UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata (VERTEBRATES). It includes nonvertebrate animals having a NOTOCHORD during some developmental stage. 688 $a2000(1966)
Old version of Record: | New version of Record:
001 D002845 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE5.$x196.$x181 150 $aChromatography 450 $wnnna$aChromatographies 667 $aGEN: prefer specifics; NIM; on Sephadex G = GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE; DF: CHROMATOGR 680 $iTechniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. 688 $a66 | 001 D002845 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE5.$x196.$x181 150 $aChromatography 450 $wnnna$aChromatographies 667 $aGEN: prefer specifics; NIM; on Sephadex G = GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE; DF: CHROMATOGR 680 $iTechniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. 688 $a66
Old version of Record: | New version of Record:
001 D002877 003 DNLM 005 20081103000000.0 008 770427 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x187.$x520.$x300 072 $aG5.$x360.$x162.$x520.$x300 150 $aChromosomes, Human 450 $wnnna$aChromosome, Human 450 $wnnna$aHuman Chromosome 450 $wnnna$aHuman Chromosomes 667 $aGEN only: prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag HUMANS will serve for these 680 $iVery long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual. 688 $a78 | 001 D002877 003 DNLM 005 20130903000000.0 008 770427 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x187.$x520.$x300 072 $aG5.$x360.$x162.$x520.$x300 150 $aChromosomes, Human 450 $wnnna$aChromosome, Human 450 $wnnna$aHuman Chromosome 450 $wnnna$aHuman Chromosomes 667 $aGEN only: prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag HUMANS will serve for these 680 $iVery long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual. 688 $a78
Old version of Record: | New version of Record:
001 D002904 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x187.$x520.$x300.$x505 072 $aG5.$x360.$x162.$x520.$x300.$x505 150 $aChromosomes, Human, 21-22 and Y 450 $wnnna$aChromosomes, Human, 21 22 450 $wnnna$aChromosomes, Human, 21-22 450 $aChromosomes G 450 $aGroup G Chromosomes 450 $wnnna$aChromosome, Group G 450 $wnnna$aChromosomes, Group G 450 $wnnna$aGroup G Chromosome 680 $iThe short, acrocentric human chromosomes, called group G in the human chromosome classification. This group consists of chromosome pairs 21 and 22 and the Y chromosome. 688 $a2001(1968) | 001 D002904 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aA11.$x284.$x187.$x520.$x300.$x505 072 $aG5.$x360.$x162.$x520.$x300.$x505 150 $aChromosomes, Human, 21-22 and Y 450 $wnnna$aChromosomes, Human, 21 22 450 $wnnna$aChromosomes, Human, 21-22 450 $aChromosomes G 450 $aGroup G Chromosomes 450 $wnnna$aChromosome, Group G 450 $wnnna$aChromosomes, Group G 450 $wnnna$aGroup G Chromosome 680 $iThe short, acrocentric human chromosomes, called group G in the human chromosome classification. This group consists of chromosome pairs 21 and 22 and the Y chromosome. 688 $a2001(1968)
Old version of Record: | New version of Record:
001 D002957 003 DNLM 005 20100901000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177 150 $aCitrus 450 $wnnna$aCitrus Fruit 450 $wnnna$aCitrus aurantium 450 $wnnna$aCitrus bergamia 450 $wnnna$aCitrus grandis 450 $wnnna$aCitrus hystrix 450 $wnnna$aCitrus limon 450 $wnnna$aCitrus maxima 450 $wnnna$aCitrus medica 450 $wnnna$aCitrus reticulata 450 $wnnna$aKaffir Lime 450 $aCitron Tree 450 $aFruit, Citrus 450 $aLemon Tree 450 $aOrange Tree, Bitter 450 $aOrange Tree, Mandarin 450 $aOrange Tree, Seville 450 $aOrange Tree, Sour 450 $aPomelo Tree 450 $aPummelo Tree 450 $aTangerine Tree 450 $wnnna$aBitter Orange Tree 450 $wnnna$aBitter Orange Trees 450 $wnnna$aCitron Trees 450 $wnnna$aCitrus Fruits 450 $wnnna$aCitrus aurantiums 450 $wnnna$aCitrus bergamias 450 $wnnna$aCitrus grandi 450 $wnnna$aCitrus hystrices 450 $wnnna$aCitrus limons 450 $wnnna$aCitrus maximas 450 $wnnna$aCitrus medicas 450 $wnnna$aCitrus reticulatas 450 $wnnna$aFruits, Citrus 450 $wnnna$aKaffir Limes 450 $wnnna$aLemon Trees 450 $wnnna$aLime, Kaffir 450 $wnnna$aLimes, Kaffir 450 $wnnna$aMandarin Orange Tree 450 $wnnna$aMandarin Orange Trees 450 $wnnna$aOrange Trees, Bitter 450 $wnnna$aOrange Trees, Mandarin 450 $wnnna$aOrange Trees, Seville 450 $wnnna$aOrange Trees, Sour 450 $wnnna$aPomelo Trees 450 $wnnna$aPummelo Trees 450 $wnnna$aSeville Orange Tree 450 $wnnna$aSeville Orange Trees 450 $wnnna$aSour Orange Tree 450 $wnnna$aSour Orange Trees 450 $wnnna$aTangerine Trees 450 $wnnna$aTree, Bitter Orange 450 $wnnna$aTree, Citron 450 $wnnna$aTree, Lemon 450 $wnnna$aTree, Mandarin Orange 450 $wnnna$aTree, Pomelo 450 $wnnna$aTree, Pummelo 450 $wnnna$aTree, Seville Orange 450 $wnnna$aTree, Sour Orange 450 $wnnna$aTree, Tangerine 450 $wnnna$aTrees, Bitter Orange 450 $wnnna$aTrees, Citron 450 $wnnna$aTrees, Lemon 450 $wnnna$aTrees, Mandarin Orange 450 $wnnna$aTrees, Pomelo 450 $wnnna$aTrees, Pummelo 450 $wnnna$aTrees, Seville Orange 450 $wnnna$aTrees, Sour Orange 450 $wnnna$aTrees, Tangerine 450 $wnnna$aaurantium, Citrus 450 $wnnna$aaurantiums, Citrus 450 $wnnna$abergamia, Citrus 450 $wnnna$abergamias, Citrus 450 $wnnna$agrandi, Citrus 450 $wnnna$agrandis, Citrus 450 $wnnna$ahystrices, Citrus 450 $wnnna$ahystrix, Citrus 450 $wnnna$alimon, Citrus 450 $wnnna$alimons, Citrus 450 $wnnna$amaxima, Citrus 450 $wnnna$amaximas, Citrus 450 $wnnna$amedica, Citrus 450 $wnnna$amedicas, Citrus 450 $wnnna$areticulata, Citrus 450 $wnnna$areticulatas, Citrus 667 $aX ref CITRUS BERGAMIA: The common name of Bergamot is also used for MONARDA, check ref; prefer specifics; as plant & fruit; juices: coord IM with BEVERAGES (IM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29 680 $iA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing. 688 $awas Citrus Fruits 1966-1997 | 001 D002957 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177 150 $aCitrus 450 $wnnna$aCitrus Fruit 450 $wnnna$aCitrus aurantium 450 $wnnna$aCitrus bergamia 450 $wnnna$aCitrus grandis 450 $wnnna$aCitrus hystrix 450 $wnnna$aCitrus limon 450 $wnnna$aCitrus maxima 450 $wnnna$aCitrus medica 450 $wnnna$aCitrus reticulata 450 $wnnna$aKaffir Lime 450 $aCitron Tree 450 $aFruit, Citrus 450 $aLemon Tree 450 $aOrange Tree, Bitter 450 $aOrange Tree, Mandarin 450 $aOrange Tree, Seville 450 $aOrange Tree, Sour 450 $aPomelo Tree 450 $aPummelo Tree 450 $aTangerine Tree 450 $wnnna$aBitter Orange Tree 450 $wnnna$aBitter Orange Trees 450 $wnnna$aCitron Trees 450 $wnnna$aCitrus Fruits 450 $wnnna$aCitrus aurantiums 450 $wnnna$aCitrus bergamias 450 $wnnna$aCitrus grandi 450 $wnnna$aCitrus hystrices 450 $wnnna$aCitrus limons 450 $wnnna$aCitrus maximas 450 $wnnna$aCitrus medicas 450 $wnnna$aCitrus reticulatas 450 $wnnna$aFruits, Citrus 450 $wnnna$aKaffir Limes 450 $wnnna$aLemon Trees 450 $wnnna$aLime, Kaffir 450 $wnnna$aLimes, Kaffir 450 $wnnna$aMandarin Orange Tree 450 $wnnna$aMandarin Orange Trees 450 $wnnna$aOrange Trees, Bitter 450 $wnnna$aOrange Trees, Mandarin 450 $wnnna$aOrange Trees, Seville 450 $wnnna$aOrange Trees, Sour 450 $wnnna$aPomelo Trees 450 $wnnna$aPummelo Trees 450 $wnnna$aSeville Orange Tree 450 $wnnna$aSeville Orange Trees 450 $wnnna$aSour Orange Tree 450 $wnnna$aSour Orange Trees 450 $wnnna$aTangerine Trees 450 $wnnna$aTree, Bitter Orange 450 $wnnna$aTree, Citron 450 $wnnna$aTree, Lemon 450 $wnnna$aTree, Mandarin Orange 450 $wnnna$aTree, Pomelo 450 $wnnna$aTree, Pummelo 450 $wnnna$aTree, Seville Orange 450 $wnnna$aTree, Sour Orange 450 $wnnna$aTree, Tangerine 450 $wnnna$aTrees, Bitter Orange 450 $wnnna$aTrees, Citron 450 $wnnna$aTrees, Lemon 450 $wnnna$aTrees, Mandarin Orange 450 $wnnna$aTrees, Pomelo 450 $wnnna$aTrees, Pummelo 450 $wnnna$aTrees, Seville Orange 450 $wnnna$aTrees, Sour Orange 450 $wnnna$aTrees, Tangerine 450 $wnnna$aaurantium, Citrus 450 $wnnna$aaurantiums, Citrus 450 $wnnna$abergamia, Citrus 450 $wnnna$abergamias, Citrus 450 $wnnna$agrandi, Citrus 450 $wnnna$agrandis, Citrus 450 $wnnna$ahystrices, Citrus 450 $wnnna$ahystrix, Citrus 450 $wnnna$alimon, Citrus 450 $wnnna$alimons, Citrus 450 $wnnna$amaxima, Citrus 450 $wnnna$amaximas, Citrus 450 $wnnna$amedica, Citrus 450 $wnnna$amedicas, Citrus 450 $wnnna$areticulata, Citrus 450 $wnnna$areticulatas, Citrus 667 $aX ref CITRUS BERGAMIA: The common name of Bergamot is also used for MONARDA, check ref; prefer specifics; as plant & fruit; juices: coord IM with BEVERAGES (IM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29 680 $iA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing. 688 $awas Citrus Fruits 1966-1997
Old version of Record: | New version of Record:
001 D003062 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD13.$x444.$x735.$x544.$x355 072 $aG5.$x360.$x335.$x355 072 $aG5.$x360.$x340.$x24.$x340.$x137.$x190 150 $aCodon 450 $aCodon, Sense 450 $aSense Codon 450 $wnnna$aCodons 450 $wnnna$aCodons, Sense 450 $wnnna$aSense Codons 550 $aReading Frames 667 $aGEN or unspecified; prefer specifics 680 $iA set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). 688 $a91(75); was see under RNA, MESSENGER 1975-90 | 001 D003062 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD13.$x444.$x735.$x544.$x355 072 $aG5.$x360.$x335.$x355 072 $aG5.$x360.$x340.$x24.$x340.$x137.$x190 150 $aCodon 450 $aCodon, Sense 450 $aSense Codon 450 $wnnna$aCodons 450 $wnnna$aCodons, Sense 450 $wnnna$aSense Codons 550 $aReading Frames 667 $aGEN or unspecified; prefer specifics 680 $iA set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). 688 $a91(75); was see under RNA, MESSENGER 1975-90
Old version of Record: | New version of Record:
001 D000024 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aI1.$x198.$x240.$x89 150 $aAbortion, Criminal 450 $wnnna$aIllegal Abortion 450 $aAbortion, Illegal 450 $wnnna$aAbortions, Criminal 450 $wnnna$aAbortions, Illegal 450 $wnnna$aCriminal Abortion 450 $wnnna$aCriminal Abortions 450 $wnnna$aIllegal Abortions 667 $a don't forget also check tags HUMANS & FEMALE & PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED 680 $iIllegal termination of pregnancy. | 001 D000024 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aI1.$x198.$x240.$x89 150 $aAbortion, Criminal 450 $wnnna$aIllegal Abortion 450 $aAbortion, Illegal 450 $wnnna$aAbortions, Criminal 450 $wnnna$aAbortions, Illegal 450 $wnnna$aCriminal Abortion 450 $wnnna$aCriminal Abortions 450 $wnnna$aIllegal Abortions 667 $a don't forget also check tags HUMANS & FEMALE & PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED 680 $iIllegal termination of pregnancy.
Old version of Record: | New version of Record:
001 D003093 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x205.$x265.$x231 072 $aC6.$x405.$x205.$x731.$x249 072 $aC6.$x405.$x469.$x158.$x188.$x231 072 $aC6.$x405.$x469.$x432.$x249 150 $aColitis, Ulcerative 450 $wnnna$aUlcerative Colitis 667 $ausually chronic so do not coord with CHRONIC DISEASE 680 $iInflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. | 001 D003093 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x205.$x265.$x231 072 $aC6.$x405.$x205.$x731.$x249 072 $aC6.$x405.$x469.$x158.$x188.$x231 072 $aC6.$x405.$x469.$x432.$x249 150 $aColitis, Ulcerative 450 $wnnna$aColitis Gravis 450 $wnnna$aIdiopathic Proctocolitis 450 $wnnna$aInflammatory Bowel Disease, Ulcerative Colitis Type 450 $wnnna$aUlcerative Colitis 667 $ausually chronic so do not coord with CHRONIC DISEASE 680 $iInflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Old version of Record: | New version of Record:
001 D003107 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x810.$x208 150 $aColorectal Surgery 450 $wnnna$aColon Surgery Specialty 450 $wnnna$aColon and Rectal Surgery Specialty 450 $wnnna$aRectal Surgery Specialty 450 $wnnna$aSpecialty, Colon Surgery 450 $wnnna$aSpecialty, Rectal Surgery 450 $wnnna$aSurgery Specialty, Colon 450 $wnnna$aSurgery Specialty, Colon and Rectal 450 $wnnna$aSurgery Specialty, Rectal 450 $wnnna$aSurgery, Colorectal 450 $aProctology 667 $aGEN only: do not confuse with COLON /surg & RECTUM /surg; SPEC: SPEC qualif DF: COLORECTAL SURG 680 $iA surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the COLON; RECTUM; and ANAL CANAL. 688 $a98; was COLON AND RECTAL SURGERY (SPECIALTY) 1980-97; was PROCTOLOGY 1963-79 | 001 D003107 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x810.$x208 150 $aColorectal Surgery 450 $wnnna$aColon Surgery Specialty 450 $wnnna$aColon and Rectal Surgery Specialty 450 $wnnna$aRectal Surgery Specialty 450 $wnnna$aSpecialty, Colon Surgery 450 $wnnna$aSpecialty, Rectal Surgery 450 $wnnna$aSurgery Specialty, Colon 450 $wnnna$aSurgery Specialty, Colon and Rectal 450 $wnnna$aSurgery Specialty, Rectal 450 $wnnna$aSurgery, Colorectal 450 $aProctology 667 $aGEN only: do not confuse with COLON /surg & RECTUM /surg; SPEC: SPEC qualif DF: COLORECTAL SURG 680 $iA surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the COLON; RECTUM; and ANAL CANAL. 688 $a98; was COLON AND RECTAL SURGERY (SPECIALTY) 1980-97; was PROCTOLOGY 1963-79
Old version of Record: | New version of Record:
001 D003117 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x751.$x941.$x256 072 $aC11.$x966.$x256 072 $aC23.$x888.$x592.$x763.$x941.$x256 150 $aColor Vision Defects 450 $wnnna$aColor Blindness, Acquired 450 $wnnna$aColor Blindness, Blue 450 $wnnna$aColor Blindness, Green 450 $wnnna$aColor Blindness, Inherited 450 $wnnna$aColor Blindness, Red 450 $wnnna$aColor Blindness, Red-Green 450 $wnnna$aDeutan Defect 450 $wnnna$aProtan Defect 450 $wnnna$aTritan Defect 450 $aAchromatopsia 450 $aColor Blindness 450 $aMonochromatopsia 450 $wnnna$aAcquired Color Blindness 450 $wnnna$aBlindness, Color 450 $wnnna$aBlue Color Blindness 450 $wnnna$aColor Blindness, Red Green 450 $wnnna$aColor Vision Defect 450 $wnnna$aDefect, Color Vision 450 $wnnna$aDefect, Deutan 450 $wnnna$aDefects, Color Vision 450 $wnnna$aGreen Color Blindness 450 $wnnna$aInherited Color Blindness 450 $wnnna$aRed Color Blindness 450 $wnnna$aRed-Green Color Blindness 450 $wnnna$aVision Defect, Color 450 $wnnna$aVision Defects, Color 550 $aColor Perception 680 $iDefects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue. 688 $a90; was COLOR BLINDNESS 1963-89 | 001 D003117 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x751.$x941.$x256 072 $aC11.$x966.$x256 072 $aC23.$x888.$x592.$x763.$x941.$x256 150 $aColor Vision Defects 450 $wnnna$aColor Blindness, Acquired 450 $wnnna$aColor Blindness, Blue 450 $wnnna$aColor Blindness, Green 450 $wnnna$aColor Blindness, Inherited 450 $wnnna$aColor Blindness, Red 450 $wnnna$aColor Blindness, Red-Green 450 $wnnna$aColor Vision Deficiency 450 $wnnna$aDeutan Defect 450 $wnnna$aProtan Defect 450 $wnnna$aTritan Defect 450 $aAchromatopsia 450 $aColor Blindness 450 $aMonochromatopsia 450 $wnnna$aAcquired Color Blindness 450 $wnnna$aBlindness, Color 450 $wnnna$aBlue Color Blindness 450 $wnnna$aColor Blindness, Red Green 450 $wnnna$aColor Vision Defect 450 $wnnna$aDefect, Color Vision 450 $wnnna$aDefect, Deutan 450 $wnnna$aDefects, Color Vision 450 $wnnna$aGreen Color Blindness 450 $wnnna$aInherited Color Blindness 450 $wnnna$aRed Color Blindness 450 $wnnna$aRed-Green Color Blindness 450 $wnnna$aVision Defect, Color 450 $wnnna$aVision Defects, Color 550 $aColor Perception 680 $iDefects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue. 688 $a90; was COLOR BLINDNESS 1963-89
Old version of Record: | New version of Record:
001 D000025 003 DNLM 005 20071115000000.0 008 741119 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE4.$x520.$x50.$x50 150 $aAbortion, Eugenic 450 $wnnna$aAbortion, Selective 450 $wnnna$aSelective Abortion 450 $aEugenic Abortion 450 $wnnna$aAbortions, Eugenic 450 $wnnna$aAbortions, Selective 450 $wnnna$aEugenic Abortions 450 $wnnna$aSelective Abortions 667 $a do not use /util except by MeSH definition; don't forget also check tags HUMANS or ANIMALS & FEMALE & PREGNANCY 680 $iAbortion performed because of possible fetal defects. 688 $a91(75); was see under ABORTION, INDUCED 1975-90 | 001 D000025 003 DNLM 005 20130903000000.0 008 741119 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE4.$x520.$x50.$x50 150 $aAbortion, Eugenic 450 $wnnna$aAbortion, Selective 450 $wnnna$aSelective Abortion 450 $aEugenic Abortion 450 $wnnna$aAbortions, Eugenic 450 $wnnna$aAbortions, Selective 450 $wnnna$aEugenic Abortions 450 $wnnna$aSelective Abortions 667 $a do not use /util except by MeSH definition; don't forget also check tags HUMANS or ANIMALS & FEMALE & PREGNANCY 680 $iAbortion performed because of possible fetal defects. 688 $a91(75); was see under ABORTION, INDUCED 1975-90
Old version of Record: | New version of Record:
001 D003144 003 DNLM 005 20120905000000.0 008 780504 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aL1.$x143.$x230 150 $aCommunication Barriers 450 $wnnna$aBarrier, Communication 450 $wnnna$aBarriers, Communication 450 $wnnna$aCommunication Barrier 667 $alanguage, cultural, sociol, etc., communication barriers; no qualif; coord IM with specific "barrier" if pertinent (IM) but if language is the barrier, note that MULTILINGUALISM is also available 680 $iThose factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups. 688 $a91(79); was see under COMMUNICATION 1979-90 | 001 D003144 003 DNLM 005 20130903000000.0 008 780504 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aL1.$x143.$x230 150 $aCommunication Barriers 450 $wnnna$aLanguage Barriers 450 $wnnna$aBarrier, Communication 450 $wnnna$aBarrier, Language 450 $wnnna$aBarriers, Communication 450 $wnnna$aBarriers, Language 450 $wnnna$aCommunication Barrier 450 $wnnna$aLanguage Barrier 667 $acoordinate IM with specific "barrier" (language, cultural, etc.) if pertinent (IM) 680 $iThose factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups. 688 $a91(79); was see under COMMUNICATION 1979-90
Old version of Record: | New version of Record:
001 D003152 003 DNLM 005 20081103000000.0 008 741111 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x478.$x676.$x150 072 $aN2.$x421.$x143.$x150 150 $aCommunity Health Nursing 450 $wnnna$aNursing, Community Health 450 $aHealth Visitors 450 $aVisiting Nurses 450 $wnnna$aCommunity Health Nursings 450 $wnnna$aHealth Nursing, Community 450 $wnnna$aHealth Nursings, Community 450 $wnnna$aHealth Visitor 450 $wnnna$aNurse, Visiting 450 $wnnna$aNurses, Visiting 450 $wnnna$aNursings, Community Health 450 $wnnna$aVisiting Nurse 450 $wnnna$aVisitor, Health 450 $wnnna$aVisitors, Health 667 $aSPEC qualif; do not confuse with PUBLIC HEALTH NURSING (a government function) 680 $iGeneral and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population. This is not an official program of a Public Health Department. 688 $a77(75); was see under COMMUNITY HEALTH SERVICES 1975-76 | 001 D003152 003 DNLM 005 20130903000000.0 008 741111 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x478.$x676.$x150 072 $aN2.$x421.$x143.$x150 150 $aCommunity Health Nursing 450 $wnnna$aNursing, Community Health 667 $ado not confuse with PUBLIC HEALTH NURSING 680 $iGeneral and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population or community. This is not an official program of a Public Health Department. 688 $a77(75); was see under COMMUNITY HEALTH SERVICES 1975-76
Old version of Record: | New version of Record:
001 D003223 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aZ1.$x58.$x290.$x100.$x140 151 $aCongo 451 $aCongo (Brazzaville) 451 $wnnna$aRepublic of the Congo 667 $aRepublic of Congo (capital at Brazzaville); do not confuse with DEMOCRATIC REPUBLIC OF THE CONGO (capital at Kinshasa, formerly Leopoldville) 680 $iA republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville. | 001 D003223 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aZ1.$x58.$x290.$x100.$x140 151 $aCongo 451 $aCongo (Brazzaville) 451 $wnnna$aRepublic of the Congo 667 $aRepublic of Congo (capital at Brazzaville); do not confuse with DEMOCRATIC REPUBLIC OF THE CONGO (capital at Kinshasa, formerly Leopoldville) 680 $iA republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville.
Old version of Record: | New version of Record:
001 D003226 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN3.$x540.$x199 150 $aCongresses as Topic 450 $wnnna$aConference Proceedings as Topic 450 $wnnna$aConferences and Congresses 450 $wnnna$aConferences and Proceedings 450 $wnnna$aCongresses and Conferences 450 $wnnna$aProfessional Meetings and Conferences 450 $aConferences 450 $wnnna$aCongresses as Topics 450 $wnnna$aProceedings and Conferences 450 $wnnna$aTopics, Congresses as 550 $aInternational Cooperation 667 $aused for general articles about congresses, conferences, or meetings as a means of communication; do not add INTERNATIONAL COOPERATION for international congresses; do not confuse with Publication Type CONGRESSES 680 $iConferences, conventions or formal meetings usually attended by delegates representing a special field of interest. 688 $a2008(1963) | 001 D003226 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN3.$x540.$x199 150 $aCongresses as Topic 450 $wnnna$aConference Proceedings as Topic 450 $wnnna$aConferences and Congresses 450 $wnnna$aConferences and Proceedings 450 $wnnna$aCongresses and Conferences 450 $wnnna$aProfessional Meetings and Conferences 450 $aConferences 450 $wnnna$aCongresses as Topics 450 $wnnna$aProceedings and Conferences 450 $wnnna$aTopics, Congresses as 550 $aInternational Cooperation 667 $aused for general articles about congresses, conferences, or meetings as a means of communication; do not add INTERNATIONAL COOPERATION for international congresses; do not confuse with Publication Type CONGRESSES 680 $iConferences, conventions or formal meetings usually attended by delegates representing a special field of interest. 688 $a2008(1963)
Old version of Record: | New version of Record:
001 D003424 003 DNLM 005 20120905000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x205.$x731.$x500 072 $aC6.$x405.$x469.$x432.$x500 150 $aCrohn Disease 450 $wnnna$aCrohn's Disease 450 $wnnna$aInflammatory Bowel Disease 1 450 $wnnna$aRegional Enteritis 450 $aColitis, Granulomatous 450 $aEnteritis, Granulomatous 450 $aEnteritis, Regional 450 $aIleitis, Regional 450 $aIleitis, Terminal 450 $aIleocolitis 450 $wnnna$aCrohns Disease 450 $wnnna$aGranulomatous Colitis 450 $wnnna$aGranulomatous Enteritis 450 $wnnna$aRegional Ileitides 450 $wnnna$aRegional Ileitis 450 $wnnna$aTerminal Ileitis 667 $acoord IM with ILEITIS (IM) or COLITIS (IM) only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE 680 $iA chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. 688 $a80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64 | 001 D003424 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x405.$x205.$x731.$x500 072 $aC6.$x405.$x469.$x432.$x500 150 $aCrohn Disease 450 $wnnna$aCrohn's Disease 450 $wnnna$aCrohn's Enteritis 450 $wnnna$aInflammatory Bowel Disease 1 450 $wnnna$aRegional Enteritis 450 $aColitis, Granulomatous 450 $aEnteritis, Granulomatous 450 $aEnteritis, Regional 450 $aIleitis, Regional 450 $aIleitis, Terminal 450 $aIleocolitis 450 $wnnna$aCrohns Disease 450 $wnnna$aGranulomatous Colitis 450 $wnnna$aGranulomatous Enteritis 450 $wnnna$aRegional Ileitides 450 $wnnna$aRegional Ileitis 450 $wnnna$aTerminal Ileitis 667 $acoord IM with ILEITIS (IM) or COLITIS (IM) only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE 680 $iA chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. 688 $a80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64
Old version of Record: | New version of Record:
001 D003550 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x689.$x202 072 $aC8.$x381.$x187 072 $aC16.$x320.$x190 072 $aC16.$x614.$x213 150 $aCystic Fibrosis 450 $wnnna$aFibrocystic Disease of Pancreas 450 $wnnna$aPancreatic Cystic Fibrosis 450 $wnnna$aPulmonary Cystic Fibrosis 450 $aMucoviscidosis 450 $wnnna$aCystic Fibrosis, Pancreatic 450 $wnnna$aCystic Fibrosis, Pulmonary 450 $wnnna$aFibrosis, Cystic 450 $wnnna$aPancreas Fibrocystic Disease 450 $wnnna$aPancreas Fibrocystic Diseases 550 $aSweating 667 $aa specific disease entity: do not use for fibrocystic states of various organs 680 $iAn autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. 688 $a67; was PANCREATIC CYSTIC FIBROSIS 1963-66 | 001 D003550 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC6.$x689.$x202 072 $aC8.$x381.$x187 072 $aC16.$x320.$x190 072 $aC16.$x614.$x213 150 $aCystic Fibrosis 450 $wnnna$aCystic Fibrosis of Pancreas 450 $wnnna$aFibrocystic Disease of Pancreas 450 $wnnna$aPancreatic Cystic Fibrosis 450 $wnnna$aPulmonary Cystic Fibrosis 450 $aMucoviscidosis 450 $wnnna$aCystic Fibrosis, Pancreatic 450 $wnnna$aCystic Fibrosis, Pulmonary 450 $wnnna$aFibrosis, Cystic 450 $wnnna$aPancreas Fibrocystic Disease 450 $wnnna$aPancreas Fibrocystic Diseases 550 $aSweating 667 $aa specific disease entity: do not use for fibrocystic states of various organs 680 $iAn autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. 688 $a67; was PANCREATIC CYSTIC FIBROSIS 1963-66
Old version of Record: | New version of Record:
001 D000337 003 DNLM 005 20100901000000.0 008 790529 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x29 150 $aAerospace Medicine 450 $wnnna$aMedicine, Aerospace 450 $wnnna$aMedicine, Aviation 450 $wnnna$aMedicine, Space 450 $aAviation Medicine 450 $aSpace Medicine 667 $aspecialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED 680 $iThat branch of medicine dealing with the studies and effects of flight through the atmosphere or in space upon the human body and with the prevention or cure of physiological or psychological malfunctions arising from these effects. (from NASA Thesaurus) 688 $a80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79 | 001 D000337 003 DNLM 005 20130903000000.0 008 790529 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH2.$x403.$x29 150 $aAerospace Medicine 450 $wnnna$aMedicine, Aerospace 450 $wnnna$aMedicine, Aviation 450 $wnnna$aMedicine, Space 450 $aAviation Medicine 450 $aSpace Medicine 550 $aAir Travel 667 $aspecialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED 680 $iThat branch of medicine dealing with the studies and effects of flight through the atmosphere or in space upon the human body and with the prevention or cure of physiological or psychological malfunctions arising from these effects. (from NASA Thesaurus) 688 $a80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79
Old version of Record: | New version of Record:
001 D003576 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD5.$x500.$x562.$x374 072 $aD8.$x811.$x600.$x250.$x687 072 $aD8.$x811.$x682.$x285 072 $aD12.$x776.$x157.$x530.$x450.$x250.$x875.$x304 072 $aD12.$x776.$x543.$x277.$x687 072 $aD12.$x776.$x543.$x585.$x450.$x250.$x875.$x484 150 $aElectron Transport Complex IV 450 $wnnna$aCytochrome Oxidase Subunit III 450 $wnnna$aCytochrome a,a3 450 $wnnna$aCytochrome c Oxidase Subunit VIa 450 $wnnna$aCytochrome-c Oxidase (Complex IV) 450 $wnnna$aCytochrome-c Oxidase Subunit III 450 $wnnna$aCytochrome-c Oxidase Subunit IV 450 $wnnna$aFerrocytochrome c Oxygen Oxidoreductase 450 $wnnna$aHeme aa3 Cytochrome Oxidase 450 $wnnna$aPre-CTOX p25 450 $wnnna$aSignal Peptide p25-Subunit IV Cytochrome Oxidase 450 $wnnna$aSubunit III, Cytochrome Oxidase 450 $wnnna$ap25 Presequence Peptide-Cytochrome Oxidase 450 $aCytochrome Oxidase 450 $aCytochrome aa3 450 $aCytochrome-c Oxidase 450 $wnnna$aCytochrome c Oxidase 450 $wnnna$aCytochrome c Oxidase Subunit III 450 $wnnna$aCytochrome c Oxidase Subunit IV 450 $wnnna$aOxidase, Cytochrome 450 $wnnna$aOxidase, Cytochrome-c 450 $wnnna$aSignal Peptide p25 Subunit IV Cytochrome Oxidase 450 $wnnna$ap25 Presequence Peptide Cytochrome Oxidase 550 $aCytochrome-c Oxidase Deficiency 667 $aspell in titles & translations with lowercase c: cytochrome-c oxidase 680 $iA multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane. 688 $a2004(1963); for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE (NM) 1988-2001; for CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE (NM) 1998-2001 | 001 D003576 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD5.$x500.$x562.$x374 072 $aD8.$x811.$x600.$x250.$x687 072 $aD8.$x811.$x682.$x285 072 $aD12.$x776.$x157.$x530.$x450.$x250.$x875.$x304 072 $aD12.$x776.$x543.$x277.$x687 072 $aD12.$x776.$x543.$x585.$x450.$x250.$x875.$x484 150 $aElectron Transport Complex IV 450 $wnnna$aCytochrome Oxidase Subunit III 450 $wnnna$aCytochrome a,a3 450 $wnnna$aCytochrome c Oxidase Subunit VIa 450 $wnnna$aCytochrome-c Oxidase (Complex IV) 450 $wnnna$aCytochrome-c Oxidase Subunit III 450 $wnnna$aCytochrome-c Oxidase Subunit IV 450 $wnnna$aFerrocytochrome c Oxygen Oxidoreductase 450 $wnnna$aHeme aa3 Cytochrome Oxidase 450 $wnnna$aPre-CTOX p25 450 $wnnna$aSignal Peptide p25-Subunit IV Cytochrome Oxidase 450 $wnnna$aSubunit III, Cytochrome Oxidase 450 $wnnna$ap25 Presequence Peptide-Cytochrome Oxidase 450 $aCytochrome Oxidase 450 $aCytochrome aa3 450 $aCytochrome-c Oxidase 450 $wnnna$aCytochrome c Oxidase 450 $wnnna$aCytochrome c Oxidase Subunit III 450 $wnnna$aCytochrome c Oxidase Subunit IV 450 $wnnna$aOxidase, Cytochrome 450 $wnnna$aOxidase, Cytochrome-c 450 $wnnna$aSignal Peptide p25 Subunit IV Cytochrome Oxidase 450 $wnnna$ap25 Presequence Peptide Cytochrome Oxidase 550 $aCytochrome-c Oxidase Deficiency 667 $aspell in titles & translations with lowercase c: cytochrome-c oxidase 680 $iA multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane. 688 $a2004(1963); for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE (NM) 1988-2001; for CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE (NM) 1998-2001
Old version of Record: | New version of Record:
001 D003582 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x158.$x273.$x343.$x180 150 $aCytogenetics 450 $wnnna$aCytogenetic 550 $aCytogenetic Analysis 550 $aChromosome Disorders 550 $aSex Chromosome Disorders 667 $aSPEC; avoid as coord: Manual 28.22.5; /methods: consider CYTOGENETIC ANALYSIS: Manual 28.22.5.2; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available 680 $iA subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE. 688 $a67 | 001 D003582 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aH1.$x158.$x273.$x343.$x180 150 $aCytogenetics 450 $wnnna$aCytogenetic 550 $aCytogenetic Analysis 550 $aChromosome Disorders 550 $aSex Chromosome Disorders 667 $aSPEC; avoid as coord: Manual 28.22.5; /methods: consider CYTOGENETIC ANALYSIS: Manual 28.22.5.2; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available 680 $iA subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE. 688 $a67
Old version of Record: | New version of Record:
001 D003634 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x455.$x526.$x439.$x255 150 $aDDT 450 $wnnna$a1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane 450 $wnnna$aBenzochloryl 450 $wnnna$aTbisC-ethane 450 $wnnna$ap',p'-DDT 667 $aTN 111 for eff on insects 680 $iA polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP-85-002, 1985). (From Merck Index, 11th ed) 688 $a1966 | 001 D003634 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x455.$x526.$x439.$x255 150 $aDDT 450 $wnnna$a1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane 450 $wnnna$a4,4'-DDT 450 $wnnna$a4,4'-Dichlorodiphenyltrichloroethane 450 $wnnna$aBenzochloryl 450 $wnnna$aChlorophenothane 450 $wnnna$aTbisC-ethane 450 $wnnna$ap',p'-DDT 450 $wnnna$a4,4' DDT 450 $wnnna$a4,4' Dichlorodiphenyltrichloroethane 450 $wnnna$aTbisC ethane 667 $aTN 111 for eff on insects 680 $iA polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP-85-002, 1985). (From Merck Index, 11th ed) 688 $a1966
Old version of Record: | New version of Record:
001 D003638 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC9.$x218.$x458.$x341.$x186 072 $aC10.$x597.$x751.$x418.$x341.$x186 072 $aC23.$x888.$x592.$x763.$x393.$x341.$x186 150 $aDeafness 450 $wnnna$aBilateral Deafness 450 $wnnna$aDeaf Mutism 450 $wnnna$aDeaf-Mutism 450 $wnnna$aDeafness, Acquired 450 $wnnna$aHearing Loss, Complete 450 $wnnna$aHearing Loss, Extreme 450 $aPrelingual Deafness 450 $wnnna$aAcquired Deafness 450 $wnnna$aComplete Hearing Loss 450 $wnnna$aDeafness, Bilateral 450 $wnnna$aDeafness, Prelingual 450 $wnnna$aExtreme Hearing Loss 550 $aLipreading 550 $aHearing Impaired Persons 667 $adifferentiate from HEARING LOSS, BILATERAL; see various specific terms under HEARING LOSS 680 $iA general term for the complete loss of the ability to hear from both ears. 688 $aDEAF-MUTISM was heading 1963-79 | 001 D003638 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC9.$x218.$x458.$x341.$x186 072 $aC10.$x597.$x751.$x418.$x341.$x186 072 $aC23.$x888.$x592.$x763.$x393.$x341.$x186 150 $aDeafness 450 $wnnna$aBilateral Deafness 450 $wnnna$aDeaf Mutism 450 $wnnna$aDeaf-Mutism 450 $wnnna$aDeafness, Acquired 450 $wnnna$aHearing Loss, Complete 450 $wnnna$aHearing Loss, Extreme 450 $aPrelingual Deafness 450 $wnnna$aAcquired Deafness 450 $wnnna$aComplete Hearing Loss 450 $wnnna$aDeafness, Bilateral 450 $wnnna$aDeafness, Prelingual 450 $wnnna$aExtreme Hearing Loss 550 $aLipreading 550 $aPersons With Hearing Impairments 667 $adifferentiate from HEARING LOSS, BILATERAL; see various specific terms under HEARING LOSS 680 $iA general term for the complete loss of the ability to hear from both ears. 688 $aDEAF-MUTISM was heading 1963-79
Old version of Record: | New version of Record:
001 D000029 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE4.$x520.$x50.$x55 150 $aAbortion, Legal 450 $aAbortion on Demand 450 $wnnna$aAbortions, Legal 450 $wnnna$aLegal Abortion 450 $wnnna$aLegal Abortions 550 $aPopulation Control 667 $a /adv eff permitted; do not use /util (except by MeSH definition) /vet; don't forget also HUMANS & FEMALE & PREGNANCY 680 $iTermination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991) 688 $a64 | 001 D000029 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE4.$x520.$x50.$x55 150 $aAbortion, Legal 450 $aAbortion on Demand 450 $wnnna$aAbortions, Legal 450 $wnnna$aLegal Abortion 450 $wnnna$aLegal Abortions 550 $aPopulation Control 667 $a /adv eff permitted; do not use /util (except by MeSH definition) /vet; don't forget also HUMANS & FEMALE & PREGNANCY 680 $iTermination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991) 688 $a64
Old version of Record: | New version of Record:
001 D003681 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC18.$x452.$x950.$x179 072 $aC23.$x550.$x274 150 $aDehydration 450 $aWater Stress 450 $wnnna$aStress, Water 550 $aBody Fluids 667 $adifferentiate from DESICCATION, a technique for removing moisture from matter; /ther: coord with ORAL REHYDRATION THERAPY see FLUID THERAPY if pertinent; do not use X ref WATER STRESS for water stress test: consider IMMERSION; permitted (NIM) with microorganisms, lower animals and plants 680 $iThe condition that results from excessive loss of water from a living organism. | 001 D003681 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC18.$x452.$x950.$x179 072 $aC23.$x550.$x274 150 $aDehydration 450 $aWater Stress 450 $wnnna$aStress, Water 550 $aBody Fluids 667 $adifferentiate from DESICCATION, a technique for removing moisture from matter; /ther: coord with ORAL REHYDRATION THERAPY see FLUID THERAPY if pertinent; do not use X ref WATER STRESS for water stress test: consider IMMERSION; permitted (NIM) with microorganisms, lower animals and plants 680 $iThe condition that results from excessive loss of water from a living organism.
Old version of Record: | New version of Record:
001 D003731 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC7.$x793.$x720.$x210 150 $aDental Caries 450 $wnnna$aDecay, Dental 450 $wnnna$aDental White Spot 450 $wnnna$aWhite Spot, Dental 450 $wnnna$aWhite Spots, Dental 450 $aCaries, Dental 450 $aDental Decay 450 $aDental White Spots 450 $aWhite Spots 450 $wnnna$aSpot, White 450 $wnnna$aSpots, White 450 $wnnna$aWhite Spot 550 $aTooth Demineralization 667 $a/drug ther: consider also CARIOSTATIC AGENTS; /etiol: consider also CARIOGENIC AGENTS & DIET, CARIOGENIC; /epidemiol: consider also DMF INDEX; DF: DENT CARIES 680 $iLocalized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp. The three most prominent theories used to explain the etiology of the disease are that acids produced by bacteria lead to decalcification; that micro-organisms destroy the enamel protein; or that keratolytic micro-organisms produce chelates that lead to 688 $aDENTAL CARIES CONTROL was heading 1965-66 | 001 D003731 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC7.$x793.$x720.$x210 150 $aDental Caries 450 $wnnna$aCarious Dentin 450 $wnnna$aDecay, Dental 450 $wnnna$aDental White Spot 450 $wnnna$aWhite Spot, Dental 450 $wnnna$aWhite Spots, Dental 450 $aCaries, Dental 450 $aDental Decay 450 $aDental White Spots 450 $aWhite Spots 450 $wnnna$aCarious Dentins 450 $wnnna$aDentin, Carious 450 $wnnna$aDentins, Carious 450 $wnnna$aSpot, White 450 $wnnna$aSpots, White 450 $wnnna$aWhite Spot 550 $aTooth Demineralization 667 $aDIET, CARIOGENIC, CARIOGENIC AGENTS, CARIOSTATIC AGENTS & DMF INDEX are also available 680 $iLocalized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp. 688 $aDENTAL CARIES CONTROL was heading 1965-66
Old version of Record: | New version of Record:
001 D000365 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x49 072 $aE1.$x370.$x350.$x700.$x50 150 $aAge Determination by Skeleton 450 $aBone Age Measurement 450 $aSkeletal Age Measurement 450 $wnnna$aAge Measurement, Bone 450 $wnnna$aAge Measurement, Skeletal 450 $wnnna$aAge Measurements, Bone 450 $wnnna$aAge Measurements, Skeletal 450 $wnnna$aBone Age Measurements 450 $wnnna$aMeasurement, Bone Age 450 $wnnna$aMeasurement, Skeletal Age 450 $wnnna$aMeasurements, Bone Age 450 $wnnna$aMeasurements, Skeletal Age 450 $wnnna$aSkeletal Age Measurements 680 $iEstablishment of the age of an individual by examination of their skeletal structure. 688 $a67; was SKELETAL AGE MEASUREMENT 1965-66 | 001 D000365 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x49 072 $aE1.$x370.$x350.$x700.$x50 150 $aAge Determination by Skeleton 450 $wnnna$aSkeletal Maturation Index 450 $aBone Age Measurement 450 $aSkeletal Age Measurement 450 $wnnna$aAge Measurement, Bone 450 $wnnna$aAge Measurement, Skeletal 450 $wnnna$aAge Measurements, Bone 450 $wnnna$aAge Measurements, Skeletal 450 $wnnna$aBone Age Measurements 450 $wnnna$aIndex, Skeletal Maturation 450 $wnnna$aIndices, Skeletal Maturation 450 $wnnna$aMaturation Index, Skeletal 450 $wnnna$aMaturation Indices, Skeletal 450 $wnnna$aMeasurement, Bone Age 450 $wnnna$aMeasurement, Skeletal Age 450 $wnnna$aMeasurements, Bone Age 450 $wnnna$aMeasurements, Skeletal Age 450 $wnnna$aSkeletal Age Measurements 450 $wnnna$aSkeletal Maturation Indices 680 $iEstablishment of the age of an individual by examination of their skeletal structure. 688 $a67; was SKELETAL AGE MEASUREMENT 1965-66
Old version of Record: | New version of Record:
001 D000369 003 DNLM 005 20071115000000.0 008 860325 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aM1.$x60.$x116.$x100.$x80 150 $aAged, 80 and over 450 $aCentenarians 450 $aNonagenarians 450 $aOctogenarians 450 $aOldest Old 450 $wnnna$aCentenarian 450 $wnnna$aNonagenarian 450 $wnnna$aOctogenarian 550 $aLongevity 667 $aNIM as check tag; IM only as psychological or sociological entity; DF: AGED 80 680 $iA person 80 years of age and older. 688 $a87; CENTENERIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95 | 001 D000369 003 DNLM 005 20130903000000.0 008 860325 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aM1.$x60.$x116.$x100.$x80 150 $aAged, 80 and over 450 $aCentenarians 450 $aNonagenarians 450 $aOctogenarians 450 $aOldest Old 450 $wnnna$aCentenarian 450 $wnnna$aNonagenarian 450 $wnnna$aOctogenarian 550 $aLongevity 667 $aNIM as check tag; IM only as psychological or sociological entity; DF: AGED 80 680 $iA person 80 years of age and older. 688 $a87; CENTENERIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95
Old version of Record: | New version of Record:
001 D000377 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x606.$x762.$x100 072 $aC23.$x888.$x592.$x604.$x764.$x100 072 $aF1.$x700.$x750.$x100 150 $aAgnosia 450 $wnnna$aAgnosia for Pain 450 $wnnna$aAgnosia for Smell 450 $wnnna$aAgnosia for Taste 450 $wnnna$aAgnosia for Temperature 450 $wnnna$aAuditory Agnosia, Congenital 450 $wnnna$aBody-Image Agnosia 450 $wnnna$aCongenital Auditory Agnosia 450 $wnnna$aDevelopmental Agnosia 450 $wnnna$aIdeational Agnosia 450 $wnnna$aOlfactory Agnosia 450 $wnnna$aPosition Agnosia 450 $wnnna$aSomatosensory Agnosia 450 $wnnna$aTime Agnosia 450 $wnnna$aTopographical Agnosia 450 $wnnna$aVisual Agnosia for Objects 450 $wnnna$aVisual Disorientation Syndrome 450 $wnnna$aVisuospatial Agnosia 450 $aAuditory Agnosia 450 $aFinger Agnosia 450 $aSensory Agnosia 450 $aTactile Agnosia 450 $aVisual Agnosia 450 $wnnna$aAgnosia for Tastes 450 $wnnna$aAgnosia, Auditory 450 $wnnna$aAgnosia, Body-Image 450 $wnnna$aAgnosia, Congenital Auditory 450 $wnnna$aAgnosia, Developmental 450 $wnnna$aAgnosia, Finger 450 $wnnna$aAgnosia, Ideational 450 $wnnna$aAgnosia, Olfactory 450 $wnnna$aAgnosia, Position 450 $wnnna$aAgnosia, Sensory 450 $wnnna$aAgnosia, Somatosensory 450 $wnnna$aAgnosia, Tactile 450 $wnnna$aAgnosia, Time 450 $wnnna$aAgnosia, Topographical 450 $wnnna$aAgnosia, Visual 450 $wnnna$aAgnosia, Visuospatial 450 $wnnna$aAgnosias 450 $wnnna$aAgnosias, Auditory 450 $wnnna$aAgnosias, Body-Image 450 $wnnna$aAgnosias, Congenital Auditory 450 $wnnna$aAgnosias, Developmental 450 $wnnna$aAgnosias, Finger 450 $wnnna$aAgnosias, Ideational 450 $wnnna$aAgnosias, Olfactory 450 $wnnna$aAgnosias, Position 450 $wnnna$aAgnosias, Sensory 450 $wnnna$aAgnosias, Somatosensory 450 $wnnna$aAgnosias, Tactile 450 $wnnna$aAgnosias, Time 450 $wnnna$aAgnosias, Topographical 450 $wnnna$aAgnosias, Visual 450 $wnnna$aAgnosias, Visuospatial 450 $wnnna$aAuditory Agnosias 450 $wnnna$aAuditory Agnosias, Congenital 450 $wnnna$aBody Image Agnosia 450 $wnnna$aBody-Image Agnosias 450 $wnnna$aCongenital Auditory Agnosias 450 $wnnna$aDevelopmental Agnosias 450 $wnnna$aFinger Agnosias 450 $wnnna$aIdeational Agnosias 450 $wnnna$aOlfactory Agnosias 450 $wnnna$aPosition Agnosias 450 $wnnna$aSensory Agnosias 450 $wnnna$aSomatosensory Agnosias 450 $wnnna$aSyndrome, Visual Disorientation 450 $wnnna$aSyndromes, Visual Disorientation 450 $wnnna$aTactile Agnosias 450 $wnnna$aTime Agnosias 450 $wnnna$aTopographical Agnosias 450 $wnnna$aVisual Agnosias 450 $wnnna$aVisual Disorientation Syndromes 450 $wnnna$aVisuospatial Agnosias 667 $acoord IM with type of stimulus that is not recognized (IM) 680 $iLoss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities. | 001 D000377 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x606.$x762.$x100 072 $aC23.$x888.$x592.$x604.$x764.$x100 072 $aF1.$x700.$x750.$x100 150 $aAgnosia 450 $wnnna$aAgnosia for Pain 450 $wnnna$aAgnosia for Smell 450 $wnnna$aAgnosia for Taste 450 $wnnna$aAgnosia for Temperature 450 $wnnna$aAnosognosia 450 $wnnna$aAuditory Agnosia, Congenital 450 $wnnna$aBody-Image Agnosia 450 $wnnna$aCongenital Auditory Agnosia 450 $wnnna$aDevelopmental Agnosia 450 $wnnna$aGustatory Agnosia 450 $wnnna$aIdeational Agnosia 450 $wnnna$aOlfactory Agnosia 450 $wnnna$aPosition Agnosia 450 $wnnna$aSomatosensory Agnosia 450 $wnnna$aTime Agnosia 450 $wnnna$aTopographical Agnosia 450 $wnnna$aVisual Agnosia for Objects 450 $wnnna$aVisual Disorientation Syndrome 450 $wnnna$aVisuospatial Agnosia 450 $aAuditory Agnosia 450 $aFinger Agnosia 450 $aSensory Agnosia 450 $aTactile Agnosia 450 $aVisual Agnosia 450 $wnnna$aAgnosia for Tastes 450 $wnnna$aAgnosia, Auditory 450 $wnnna$aAgnosia, Body-Image 450 $wnnna$aAgnosia, Congenital Auditory 450 $wnnna$aAgnosia, Developmental 450 $wnnna$aAgnosia, Finger 450 $wnnna$aAgnosia, Gustatory 450 $wnnna$aAgnosia, Ideational 450 $wnnna$aAgnosia, Olfactory 450 $wnnna$aAgnosia, Position 450 $wnnna$aAgnosia, Sensory 450 $wnnna$aAgnosia, Somatosensory 450 $wnnna$aAgnosia, Tactile 450 $wnnna$aAgnosia, Time 450 $wnnna$aAgnosia, Topographical 450 $wnnna$aAgnosia, Visual 450 $wnnna$aAgnosia, Visuospatial 450 $wnnna$aAgnosias 450 $wnnna$aAgnosias, Auditory 450 $wnnna$aAgnosias, Body-Image 450 $wnnna$aAgnosias, Congenital Auditory 450 $wnnna$aAgnosias, Developmental 450 $wnnna$aAgnosias, Finger 450 $wnnna$aAgnosias, Ideational 450 $wnnna$aAgnosias, Olfactory 450 $wnnna$aAgnosias, Position 450 $wnnna$aAgnosias, Sensory 450 $wnnna$aAgnosias, Somatosensory 450 $wnnna$aAgnosias, Tactile 450 $wnnna$aAgnosias, Time 450 $wnnna$aAgnosias, Topographical 450 $wnnna$aAgnosias, Visual 450 $wnnna$aAgnosias, Visuospatial 450 $wnnna$aAnosognosias 450 $wnnna$aAuditory Agnosias 450 $wnnna$aAuditory Agnosias, Congenital 450 $wnnna$aBody Image Agnosia 450 $wnnna$aBody-Image Agnosias 450 $wnnna$aCongenital Auditory Agnosias 450 $wnnna$aDevelopmental Agnosias 450 $wnnna$aFinger Agnosias 450 $wnnna$aIdeational Agnosias 450 $wnnna$aOlfactory Agnosias 450 $wnnna$aPosition Agnosias 450 $wnnna$aSensory Agnosias 450 $wnnna$aSomatosensory Agnosias 450 $wnnna$aSyndrome, Visual Disorientation 450 $wnnna$aSyndromes, Visual Disorientation 450 $wnnna$aTactile Agnosias 450 $wnnna$aTime Agnosias 450 $wnnna$aTopographical Agnosias 450 $wnnna$aVisual Agnosias 450 $wnnna$aVisual Disorientation Syndromes 450 $wnnna$aVisuospatial Agnosias 667 $acoordinate IM with type of stimulus that is not recognized (IM) 680 $iLoss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.
Old version of Record: | New version of Record:
001 D003920 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC18.$x452.$x394.$x750 072 $aC19.$x246 150 $aDiabetes Mellitus 550 $aDiabetes Insipidus 550 $aGlucose Intolerance 667 $aGEN or unspecified; prefer specifics; pregnancy of diabetic patients = PREGNANCY IN DIABETICS but do not confuse with DIABETES, GESTATIONAL: see note there; PREDIABETIC STATE is also available & includes subclinical diabetes; /diet ther: consider coord with DIABETIC DIET but see note there; alloxan- & streptozocin-induced diabetes: see note on DIABETES MELLITUS, EXPERIMENTAL 680 $iA heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 001 D003920 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC18.$x452.$x394.$x750 072 $aC19.$x246 150 $aDiabetes Mellitus 550 $aDiabetes Insipidus 550 $aGlucose Intolerance 667 $aGEN or unspecified; prefer specifics; pregnancy of diabetic patients = PREGNANCY IN DIABETICS but do not confuse with DIABETES, GESTATIONAL: see note there; PREDIABETIC STATE is also available & includes subclinical diabetes; /diet ther: consider coord with DIABETIC DIET but see note there; alloxan- & streptozocin-induced diabetes: see note on DIABETES MELLITUS, EXPERIMENTAL 680 $iA heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Old version of Record: | New version of Record:
001 D003952 003 DNLM 005 20071115000000.0 008 870316 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x350 150 $aDiagnostic Imaging 450 $aImaging, Diagnostic 450 $aImaging, Medical 450 $aMedical Imaging 667 $ageneral: prefer specific techniques 680 $iAny visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. 688 $a88 | 001 D003952 003 DNLM 005 20130903000000.0 008 870316 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x350 150 $aDiagnostic Imaging 450 $aImaging, Diagnostic 450 $aImaging, Medical 450 $aMedical Imaging 550 $aImage Processing, Computer-Assisted 667 $ageneral: prefer specific techniques 680 $iAny visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. 688 $a88
Old version of Record: | New version of Record:
001 D003967 003 DNLM 005 20090831000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC23.$x888.$x821.$x214 150 $aDiarrhea 450 $wnnna$aDiarrheas 550 $aDefecation 550 $aFoodborne Diseases 667 $ain infants = DIARRHEA, INFANTILE + appropriate check tags 680 $iAn increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. | 001 D003967 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC23.$x888.$x821.$x214 150 $aDiarrhea 450 $wnnna$aDiarrheas 550 $aDefecation 550 $aFoodborne Diseases 667 $ain infants = DIARRHEA, INFANTILE + appropriate check tags 680 $iAn increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
Old version of Record: | New version of Record:
001 D004020 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aL1.$x178.$x682.$x192.$x836.$x285.$x561 150 $aDictionaries, Polyglot 450 $wnnna$aDictionary, Polyglot 450 $wnnna$aPolyglot Dictionaries 450 $wnnna$aPolyglot Dictionary 667 $aIM for polyglot dictionaries as a subject; for articles listing terms & definitions in different languages, index under specific subject (IM) + DICTIONARIES, POLYGLOT (NIM) + DICTIONARY (PT); CATALOG: use only for works about polyglot dictionaries; for items which actually are polyglot dictionaries, use DICTIONARY | 001 D004020 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aL1.$x178.$x682.$x192.$x836.$x285.$x561 150 $aDictionaries, Polyglot 450 $wnnna$aDictionary, Polyglot 450 $wnnna$aPolyglot Dictionaries 450 $wnnna$aPolyglot Dictionary 667 $aIM for polyglot dictionaries as a subject; for articles listing terms & definitions in different languages, index under specific subject (IM) + DICTIONARIES, POLYGLOT (NIM) + DICTIONARY (PT); CATALOG: use only for works about polyglot dictionaries; for items which actually are polyglot dictionaries, use DICTIONARY
Old version of Record: | New version of Record:
001 D004175 003 DNLM 005 20100901000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x50.$x500.$x131.$x617.$x289 150 $aDiptera 450 $wnnna$aFlies 450 $aFlies, True 450 $wnnna$aDipteras 450 $wnnna$aFly 450 $wnnna$aFly, True 450 $wnnna$aTrue Flies 450 $wnnna$aTrue Fly 667 $afor killing Diptera with insecticides, see note at INSECTICIDES; FIREFLIES is also available; index caddisfly, dragonfly, mayfly & stonefly under INSECTS; index sawfly & ichneumon fly under HYMENOPTERA; infestation by fly maggots = MYIASIS 680 $iAn order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA). 688 $a81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74 | 001 D004175 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aB1.$x50.$x500.$x131.$x617.$x289 150 $aDiptera 450 $wnnna$aFlies 450 $aFlies, True 450 $wnnna$aDipteras 450 $wnnna$aFly 450 $wnnna$aFly, True 450 $wnnna$aTrue Flies 450 $wnnna$aTrue Fly 667 $afor killing Diptera with insecticides, see note at INSECTICIDES; DRAGONFLY & DAMSELFLY see ODONATA & FIREFLIES are also available; index caddisfly, mayfly & stonefly under INSECTS; index sawfly & ichneumon fly under HYMENOPTERA; infestation by fly maggots = MYIASIS 680 $iAn order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA). 688 $a81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74
Old version of Record: | New version of Record:
001 D004185 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x400 150 $aDisability Evaluation 450 $wnnna$aDisability Evaluations 450 $wnnna$aEvaluation, Disability 450 $wnnna$aEvaluations, Disability 550 $aEligibility Determination 550 $aRehabilitation 550 $aWorkers' Compensation 667 $ano qualif 680 $iDetermination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits. | 001 D004185 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE1.$x370.$x400 150 $aDisability Evaluation 450 $wnnna$aDisability Evaluations 450 $wnnna$aEvaluation, Disability 450 $wnnna$aEvaluations, Disability 550 $aEligibility Determination 550 $aRehabilitation 550 $aWorkers' Compensation 550 $aInternational Classification of Functioning, Disability and Health 667 $ano qualif 680 $iDetermination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.
Old version of Record: | New version of Record:
001 D004194 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC23.$x550.$x288 150 $aDisease 450 $wnnna$aDiseases 667 $ageneral only as a physiological, pathological, philosophical concept, opposite "health"; Manual 23.5+; / econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; / psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS 680 $iA definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. | 001 D004194 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC23.$x550.$x288 150 $aDisease 450 $wnnna$aDiseases 667 $ageneral only as a physiological, pathological, philosophical concept, opposite "health"; Manual 23.5+; / econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; / psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS 680 $iA definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Old version of Record: | New version of Record:
001 D000428 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aF1.$x145.$x317.$x269 150 $aAlcohol Drinking 450 $aAlcohol Consumption 450 $aDrinking, Alcohol 450 $wnnna$aConsumption, Alcohol 550 $aDrinking 667 $adrunkenness = ALCOHOLIC INTOXICATION but binge drinking & acute alcohol intox = ETHANOL /pois; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available for "abstinence from alcohol" but do not confuse with alcohol withdrawal (see note under ALCOHOL WITHDRAWAL DELIRIUM & SUBSTANCE WITHDRAWAL SYNDROME) 680 $iBehaviors associated with the ingesting of alcoholic beverages, including social drinking. 688 $a69 | 001 D000428 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aF1.$x145.$x317.$x269 150 $aAlcohol Drinking 450 $aAlcohol Consumption 450 $aDrinking, Alcohol 450 $wnnna$aConsumption, Alcohol 550 $aDrinking 667 $aavailable also are BINGE DRINKING and DRUNKENNESS see ALCOHOLIC INTOXICATION; acute alcohol intoxication = ETHANOL / pois; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available for "abstinence from alcohol" but do not confuse with alcohol withdrawal (see note under ALCOHOL WITHDRAWAL DELIRIUM & SUBSTANCE WITHDRAWAL SYNDROME) 680 $iBehaviors associated with the ingesting of alcoholic beverages, including social drinking. 688 $a69
Old version of Record: | New version of Record:
001 D004298 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x92.$x211.$x215.$x311.$x342 072 $aD2.$x92.$x311.$x342 150 $aDopamine 450 $wnnna$a3,4-Dihydroxyphenethylamine 450 $wnnna$a4-(2-Aminoethyl)-1,2-benzenediol 450 $wnnna$aDopamine Hydrochloride 450 $wnnna$aIntropin 450 $aHydroxytyramine 450 $wnnna$a3,4 Dihydroxyphenethylamine 450 $wnnna$aHydrochloride, Dopamine 550 $aDihydroxyphenylalanine 550 $aLevodopa 680 $iOne of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. | 001 D004298 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x92.$x211.$x215.$x311.$x342 072 $aD2.$x92.$x311.$x342 150 $aDopamine 450 $wnnna$a3,4-Dihydroxyphenethylamine 450 $wnnna$a4-(2-Aminoethyl)-1,2-benzenediol 450 $wnnna$aDopamine Hydrochloride 450 $wnnna$aIntropin 450 $aHydroxytyramine 450 $wnnna$a3,4 Dihydroxyphenethylamine 450 $wnnna$aHydrochloride, Dopamine 550 $aDihydroxyphenylalanine 550 $aLevodopa 680 $iOne of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Old version of Record: | New version of Record:
001 D004314 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x606.$x643.$x220 072 $aC16.$x131.$x77.$x327 072 $aC16.$x131.$x260.$x260 072 $aC16.$x320.$x180.$x260 150 $aDown Syndrome 450 $wnnna$aDown Syndrome, Partial Trisomy 21 450 $wnnna$aDown's Syndrome 450 $wnnna$aPartial Trisomy 21 Down Syndrome 450 $wnnna$aTrisomy 21, Meiotic Nondisjunction 450 $wnnna$aTrisomy 21, Mitotic Nondisjunction 450 $aMongolism 450 $aTrisomy 21 450 $wnnna$aDowns Syndrome 450 $wnnna$aSyndrome, Down 450 $wnnna$aSyndrome, Down's 550 $aIntellectual Disability 680 $iA chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) 688 $a93; was DOWN'S SYNDROME 1975-92 & 1963-64; was MONGOLISM 1965-74 | 001 D004314 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC10.$x597.$x606.$x643.$x220 072 $aC16.$x131.$x77.$x327 072 $aC16.$x131.$x260.$x260 072 $aC16.$x320.$x180.$x260 150 $aDown Syndrome 450 $wnnna$a47,XX,+21 450 $wnnna$a47,XY,+21 450 $wnnna$aDown Syndrome, Partial Trisomy 21 450 $wnnna$aDown's Syndrome 450 $wnnna$aPartial Trisomy 21 Down Syndrome 450 $wnnna$aTrisomy 21, Meiotic Nondisjunction 450 $wnnna$aTrisomy 21, Mitotic Nondisjunction 450 $wnnna$aTrisomy G 450 $aMongolism 450 $aTrisomy 21 450 $wnnna$aDowns Syndrome 450 $wnnna$aSyndrome, Down 450 $wnnna$aSyndrome, Down's 550 $aIntellectual Disability 680 $iA chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) 688 $a93; was DOWN'S SYNDROME 1975-92 & 1963-64; was MONGOLISM 1965-74
Old version of Record: | New version of Record:
001 D004337 003 DNLM 005 20071115000000.0 008 870504 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x255.$x260 072 $aD27.$x720.$x280.$x260 072 $aE2.$x319.$x300.$x380 150 $aDrug Carriers 450 $wnnna$aDrug Carrier 550 $aDrug Delivery Systems 667 $acoord with specific drug 680 $iForms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, an 688 $a88 | 001 D004337 003 DNLM 005 20130903000000.0 008 870504 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26.$x255.$x260 072 $aD27.$x720.$x280.$x260 072 $aE2.$x319.$x300.$x380 150 $aDrug Carriers 450 $wnnna$aDrug Carrier 550 $aDrug Delivery Systems 667 $acoord with specific drug 680 $iForms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. 688 $a88
Old version of Record: | New version of Record:
001 D004342 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC20.$x543.$x206 150 $aDrug Hypersensitivity 450 $wnnna$aDrug Allergy 450 $aAllergy, Drug 450 $aHypersensitivity, Drug 450 $wnnna$aAllergies, Drug 450 $wnnna$aDrug Allergies 450 $wnnna$aDrug Hypersensitivities 450 $wnnna$aHypersensitivities, Drug 450 $aHypersensitivity$xchemically induced 667 $ause in conventional sense and not for allergy to every category D term; allergy to non-drug chemical substance=substance /ad eff + HYPERSENSITIVITY or its specifics /etiol; manual 23.24+ 680 $iImmunologically mediated adverse reactions to medicinal substances used legally or illegally. 688 $a66; was DRUG ALLERGY 1963-65 | 001 D004342 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC20.$x543.$x206 072 $aC25.$x100.$x468 150 $aDrug Hypersensitivity 450 $wnnna$aDrug Allergy 450 $aAllergy, Drug 450 $aHypersensitivity, Drug 450 $wnnna$aAllergies, Drug 450 $wnnna$aDrug Allergies 450 $wnnna$aDrug Hypersensitivities 450 $wnnna$aHypersensitivities, Drug 450 $aHypersensitivity$xchemically induced 550 $aDrug Hypersensitivity Syndrome 667 $ause in conventional sense and not for allergy to every category D term; allergy to non-drug chemical substance=substance /ad eff + HYPERSENSITIVITY or its specifics /etiol; manual 23.24+ 680 $iImmunologically mediated adverse reactions to medicinal substances used legally or illegally. 688 $a66; was DRUG ALLERGY 1963-65
Old version of Record: | New version of Record:
001 D004347 003 DNLM 005 20081103000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG7.$x690.$x812.$x240 072 $aG7.$x700.$x680.$x240 150 $aDrug Interactions 450 $wnnna$aDrug Interaction 450 $wnnna$aInteraction, Drug 450 $wnnna$aInteractions, Drug 550 $aMetabolic Detoxication, Phase I 550 $aDrug Toxicity 667 $ado not confuse with DRUG INCOMPATIBILITY; IM when general; NIM with specific drugs (IM) 680 $iThe action of a drug that may affect the activity, metabolism, or toxicity of another drug. 688 $a72 | 001 D004347 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aG7.$x690.$x812.$x240 072 $aG7.$x700.$x680.$x240 150 $aDrug Interactions 450 $wnnna$aDrug Interaction 450 $wnnna$aInteraction, Drug 450 $wnnna$aInteractions, Drug 550 $aMetabolic Detoxication, Phase I 550 $aDrug-Related Side Effects and Adverse Reactions 667 $ado not confuse with DRUG INCOMPATIBILITY; IM when general; NIM with specific drugs (IM) 680 $iThe action of a drug that may affect the activity, metabolism, or toxicity of another drug. 688 $a72
Old version of Record: | New version of Record:
001 D004349 003 DNLM 005 20110909000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE5.$x916.$x320 072 $aJ1.$x576.$x318.$x321 072 $aJ1.$x576.$x761.$x300 150 $aDrug Packaging 450 $wnnna$aDrug Containers 450 $aDrug Containers and Closures 450 $aPackaging, Drug 450 $wnnna$aContainer, Drug 450 $wnnna$aContainers, Drug 450 $wnnna$aDrug Container 450 $wnnna$aDrug Packagings 450 $wnnna$aPackagings, Drug 667 $aincludes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available 680 $iContainers, packaging, and packaging materials for drugs and BIOLOGICAL AGENTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG 688 $a78; was DRUG CONTAINERS AND CLOSURES 1968-77 | 001 D004349 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aE5.$x916.$x320 072 $aJ1.$x576.$x318.$x321 072 $aJ1.$x576.$x761.$x300 150 $aDrug Packaging 450 $wnnna$aDrug Containers 450 $aDrug Containers and Closures 450 $aPackaging, Drug 450 $wnnna$aContainer, Drug 450 $wnnna$aContainers, Drug 450 $wnnna$aDrug Container 450 $wnnna$aDrug Packagings 450 $wnnna$aPackagings, Drug 667 $aincludes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available 680 $iContainers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. 688 $a78; was DRUG CONTAINERS AND CLOSURES 1968-77
Old version of Record: | New version of Record:
001 D000431 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x33.$x375 150 $aEthanol 450 $wnnna$aAbsolute Alcohol 450 $wnnna$aGrain Alcohol 450 $aAlcohol, Ethyl 450 $wnnna$aAlcohol, Absolute 450 $wnnna$aAlcohol, Grain 450 $wnnna$aEthyl Alcohol 667 $afor "alcohol" unspecified; /antag: consider also ALCOHOL DETERRENTS; ethanol production by organisms = /metab; /pois: for acute alcohol pois, acute alcoholic intox, binge drinking, but ALCOHOLIC INTOXICATION is available for drunkenness & ALCOHOLISM for chronic alcohol intox; consider also ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed; "abstinence from alcohol" = TEMPERANCE 680 $iA clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. 688 $a98(63) | 001 D000431 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD2.$x33.$x375 150 $aEthanol 450 $wnnna$aAbsolute Alcohol 450 $wnnna$aGrain Alcohol 450 $aAlcohol, Ethyl 450 $wnnna$aAlcohol, Absolute 450 $wnnna$aAlcohol, Grain 450 $wnnna$aEthyl Alcohol 667 $afor "alcohol" unspecified; / antag: consider also ALCOHOL DETERRENTS; ethanol production by organisms = / metab; use/ pois for acute alcohol poisoning & acute alcoholic intoxication; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION, ALCOHOLISM and ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed; "abstinence from alcohol" = TEMPERANCE 680 $iA clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. 688 $a98(63)
Old version of Record: | New version of Record:
001 D004364 003 DNLM 005 20120905000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26 150 $aPharmaceutical Preparations 450 $wnnna$aPharmaceutic Preparations 450 $wnnna$aPharmaceutical Products 450 $wnnna$aPreparations, Pharmaceutical 450 $aDrugs 450 $wnnna$aPreparations, Pharmaceutic 450 $wnnna$aProducts, Pharmaceutical 550 $aPharmacology 550 $aDrug Dosage Calculations 667 $ageneral or unspecified only; /adv eff permitted but consider DRUG THERAPY/adv eff; drug names: use NOMENCLATURE; policy: Manual section 25 680 $iDrugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. 688 $a98(63) | 001 D004364 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aD26 150 $aPharmaceutical Preparations 450 $wnnna$aPharmaceutic Preparations 450 $wnnna$aPharmaceutical Products 450 $wnnna$aPreparations, Pharmaceutical 450 $aDrugs 450 $wnnna$aPreparations, Pharmaceutic 450 $wnnna$aProducts, Pharmaceutical 550 $aPharmacology 550 $aDrug Dosage Calculations 667 $ageneral or unspecified only; prefer specific drugs; drug names: use NOMENCLATURE; policy: Manual chapter 25 680 $iDrugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. 688 $a98(63)
Old version of Record: | New version of Record:
001 D000436 003 DNLM 005 20071115000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN3.$x540.$x782.$x270 150 $aAlcoholics Anonymous 450 $wnnna$aAnonymous, Alcoholics 550 $aAlcoholism 667 $aIM CATALOG: use NAF Entry 680 $iAn organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence. 688 $a74 | 001 D000436 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aN3.$x540.$x782.$x270 150 $aAlcoholics Anonymous 450 $wnnna$aAnonymous, Alcoholics 550 $aAlcoholism 667 $aIM CATALOG: use NAF Entry 680 $iAn organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence. 688 $a74
Old version of Record: | New version of Record:
001 D000437 003 DNLM 005 20120905000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC25.$x100.$x250 072 $aF3.$x900.$x100.$x350 150 $aAlcoholism 450 $wnnna$aAlcohol Dependence 450 $aAlcohol Abuse 450 $aAlcoholic Intoxication, Chronic 450 $wnnna$aAbuse, Alcohol 450 $wnnna$aChronic Alcoholic Intoxication 450 $wnnna$aIntoxication, Chronic Alcoholic 550 $aAlcohol Drinking 550 $aSocial Problems 667 $ahuman & animal; do not coord with CHRONIC DISEASE: alcoholism is presumed to be chronic; differentiate from ALCOHOLIC INTOXICATION, being drunk, not chronic; acute alcoholic intox & binge drinking is ETHANOL /pois; /drug ther: consider also ALCOHOL DETERRENTS; consider also LIVER DISEASES, ALCOHOLIC & its specifics FATTY LIVER, ALCOHOLIC; HEPATITIS, ALCOHOLIC & LIVER CIRRHOSIS, ALCOHOLIC; also PANCREATITIS, ALCOHOLIC; also CARDIOMYOPATHY, ALCOHOLIC; PSYCHOSES, ALCOHOLIC & FETAL ALCOHOL SYNDROME; index o 680 $iA primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) | 001 D000437 003 DNLM 005 20130903000000.0 008 990101 n ancnnbabn || ana 040 $aDNLM$cDNLM 072 $aC25.$x775.$x100.$x250 072 $aF3.$x900.$x100.$x350 150 $aAlcoholism 450 $wnnna$aAlcohol Addiction 450 $wnnna$aAlcohol Dependence 450 $aAlcohol Abuse 450 $aAlcoholic Intoxication, Chronic 450 $wnnna$aAbuse, Alcohol 450 $wnnna$aAddiction, Alcohol 450 $wnnna$aChronic Alcoholic Intoxication 450 $wnnna$aDependence, Alcohol 450 $wnnna$aIntoxication, Chronic Alcoholic 550 $aAlcohol Drinking 550 $aSocial Problems 550 $aFetal Alcohol Spectrum Disorders 667 $ahuman & animal; note entry term ALCOHOLIC INTOXICATION, CHRONIC: do not coordinate with CHRONIC DISEASE; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION and ALCOHOLICS; acute alcoholic intoxication = ETHANOL /pois; consider also ALCOHOL-INDUCED DISORDERS and specifics; index other complications of alcoholism under ALCOHOLISM /compl (IM) + disease /etiol not /chem ind (IM); abstinence from alcohol in alcoholism: coordinate with TEMPERANCE (NIM) 680 $iA primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)